Reimbursement for rheumatic diseases

K11_REIMB_202

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: KELA reimbursements: KELA codes — 202 1 out of 7 registries used, show all original rules.	33832
4. Check minimum number of events None	33832
5. Include endpoints None	33832
6. Filter based on genotype QC (FinnGen only)	30880

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	K11_REIMB_202
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	202
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Reimbursement for rheumatic diseases based on the number of shared cases.

Similar with more cases:

Any reimbursement code in KELA

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	185643	118766	65381
Only index persons	152213	98524	53689
Unadjusted period prevalence (%)
Whole population	2.83	3.40	1.83
Only index persons	3.07	3.62	2.05
Median age at first event (years)
Whole population	50.41	50.90	49.45
Only index persons	48.67	49.22	47.66

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	30880	20147	10733
Unadjusted period prevalence (%)	6.38	7.15	4.92
Median age at first event (years)	48.89	47.75	51.03

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
31821: Matched controls
316124

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

12.0

322.8

327

274

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

6.0

322.4

576

968

M01AB55

ATC

diclofenac, combinations; oral

2.4

318.6

2309

9876

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

318.5

3654

18834

J01FF01

ATC

clindamycin; systemic

1.7

314.8

8510

56944

S91

ICPC

Psoriasis

6.5

312.3

512

789

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

6.0

309.6

553

929

RK220, ,

NOMESCO Finland

14.7

308.9

277

189

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

307.7

9314

62150

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

213.3

307.7

3886

206

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

7.3

307.7

649

901

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

37.3

307.7

246

M17.5

ICD-10 Finland

Other secondary gonarthrosis

5.3

307.7

689

1322

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

8.9

307.7

566

643

3006

Kela drug reimbursment

Baricitinib

565.6

307.7

339

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

9.7

307.7

2061

2230

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.9

307.7

996

2590

3029

Kela drug reimbursment

Upadacitinib

32.2

307.7

327

102

M01CB03

ATC

auranofin; oral

257.2

307.7

1100

M07.3

ICD-10 Finland

Other psoriatic arthropathies

103.0

307.7

1662

169

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

6.8

307.7

538

793

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.8

307.7

16740

71907

L01BA01

ATC

methotrexate; systemic

211.5

307.7

7521

462

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

11.3

307.7

1665

1540

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

307.7

3710

16686

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

307.7

14180

101100

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

315.4

307.7

592

L04AA44

ATC

[U] upadacitinib

60.9

307.7

213

L20

ICPC

Joint symptom/complaint NOS

3.7

307.7

1985

5555

H02AB07

ATC

prednisone; oral

3.5

307.7

6785

22856

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

14.8

307.7

1087

755

NH3EA

NOMESCO Finland

Feet X-ray examination with load

15.8

307.7

2064

1386

RT271, ,

NOMESCO Finland

69.6

307.7

271

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

5.7

307.7

2488

4615

M13.8

ICD-10 Finland

Other specified arthritis

9.9

307.7

743

764

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

97.7

307.7

215

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

15.8

307.7

733

470

WZA10

NOMESCO Finland

Extensive medical or dental certificate

14.3

307.7

1347

972

M13.0

ICD-10 Finland

Polyarthritis, unspecified

15.2

307.7

1144

774

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

4.4

307.7

987

2307

L40.0

ICD-10 Finland

Psoriasis vulgaris

4.5

307.7

2312

5444

S01BA01

ATC

dexamethasone; ophthalmic

3.3

307.7

1450

4453

M31.3

ICD-10 Finland

Wegener granulomatosis

26.5

307.7

335

127

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

9.0

307.7

420

469

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

85.4

307.7

205

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

61.8

307.7

381

RT272, ,

NOMESCO Finland

39.9

307.7

369

A02BC02

ATC

pantoprazole; systemic

2.0

307.7

22854

177471

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.4

307.7

3880

9702

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

31.6

307.7

865

279

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

35.3

307.7

306

NG1DA

NOMESCO Finland

X-ray of knees

6.3

307.7

1097

1780

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

38.8

307.7

1460

391

M01AH05

ATC

etoricoxib; oral

1.9

307.7

20793

158838

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

+∞

307.7

31821

M34.1

ICD-10 Finland

CR(E)ST syndrome

26.3

307.7

408

156

H02AB08

ATC

triamcinolone; systemic

27.7

307.7

383

139

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

8.1

307.7

1072

1363

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

73.9

307.7

1517

214

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

144.0

307.7

173

L04AC10

ATC

secukinumab; parenteral

74.8

307.7

685

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

20.4

307.7

338

166

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

223.7

307.7

268

M05BA07

ATC

risedronic acid; oral

3.9

307.7

1362

3627

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

254.8

307.7

1538

D07XC01

ATC

betamethasone; topical

2.1

307.7

4111

20617

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.7

307.7

1621

4480

L04AD01

ATC

ciclosporin; systemic

9.1

307.7

1350

1524

L04AA17

ATC

[U] adalimumab

4965.6

307.7

502

L04AC07

ATC

tocilizumab; parenteral

657.4

307.7

586

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

26.4

307.7

287

109

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

18.3

307.7

1429

808

K83.0

ICD-10 Finland

Cholangitis

5.6

307.7

737

1328

K74.3

ICD-10 Finland

Primary biliary cirrhosis

43.5

307.7

677

158

NDL52

NOMESCO Finland

Tenosynovectomy of hand

21.3

307.7

655

311

L04AA11

ATC

[U] etanercept

362.3

307.7

573

NDF10

NOMESCO Finland

Synovectomy of wrist

67.3

307.7

222

L04AA06

ATC

mycophenolic acid; systemic

5.9

307.7

1104

1929

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

6.2

307.7

1135

1876

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

5.4

307.7

846

1579

M01AH02

ATC

rofecoxib; oral

2.0

307.7

4219

21960

H02AB04

ATC

methylprednisolone; systemic

2.3

307.7

5565

26390

L04AK01

ATC

leflunomide; oral

228.1

307.7

1108

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

41.5

307.7

11665

4351

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

83.2

307.7

397

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

113.3

307.7

383

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1613.3

307.7

6975

H02AB06

ATC

prednisolone; systemic

5.7

307.7

23756

107585

M35.1

ICD-10 Finland

Other overlap syndromes

30.1

307.7

489

164

R4180

NOMESCO Finland

Podiatric therapy

5.8

307.7

628

1085

A07EC01

ATC

sulfasalazine; oral, rectal

94.4

307.7

16388

3518

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.8

307.7

2411

4376

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

38.7

307.7

205

M45

ICD-10 Finland

Ankylosing spondylitis

66.4

307.7

3546

596

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

221.7

307.7

375

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

14.2

307.7

1251

910

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

10.3

307.7

991

979

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

7.2

307.7

597

840

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

307.7

18733

107594

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

19.2

307.7

1989

1092

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

87.1

307.7

5524

761

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

227.3

307.7

803

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

21.2

307.7

799

384

M06

ICD-10 Finland

Other rheumatoid arthritis

133.9

307.7

904

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

124.7

307.7

1161

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

24.3

307.7

901

378

9284

FHL

Wrist ossification surgery

162.4

307.7

195

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.0

307.7

2562

9103

M01AH01

ATC

celecoxib; oral

2.3

307.7

6953

34280

M01AC06

ATC

meloxicam; systemic, rectal

2.0

307.7

12653

79683

9522

FHL

Synovectomy

90.5

307.7

289

L04AB06

ATC

golimumab; parenteral

206.2

307.7

1522

L04AB05

ATC

certolizumab pegol; parenteral

1125.5

307.7

882

L04AA13

ATC

[U] leflunomide

401.3

307.7

4862

142

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

166.8

307.7

167

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.4

307.7

2234

6935

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

303.9

307.7

482

M25.5

ICD-10 Finland

Pain in joint

2.1

307.7

12701

74654

298, ,

Kela drug reimbursment

37.1

307.7

325

NF1AA

NOMESCO Finland

Hip X-ray examination

2.3

307.7

3303

15049

M05.0

ICD-10 Finland

Felty syndrome

106.7

307.7

171

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.6

307.7

1664

4761

D05AX02

ATC

calcipotriol; topical

4.1

307.7

1763

4418

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

6.5

307.7

626

968

293

Kela drug reimbursment

Baricitinib

+∞

307.7

325

NDG30

NOMESCO Finland

Fusion of wrist, total

43.6

307.7

594

138

L04AA32

ATC

apremilast; oral

24.6

307.7

294

120

M13.9

ICD-10 Finland

Arthritis, unspecified

11.3

307.7

7741

8765

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

11.0

307.7

1637

1554

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

5.5

307.7

6401

13839

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.5

307.7

889

1991

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

62.2

307.7

1926

327

L04AX01

ATC

azathioprine; systemic

9.4

307.7

3687

4329

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.9

307.7

1986

5281

NH3AE

NOMESCO Finland

Feet ultrasound examination

30.9

307.7

333

108

TNG10

NOMESCO Finland

Puncture of knee

29.5

307.7

1400

493

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2065.1

307.7

6593

H20.1

ICD-10 Finland

Chronic iridocyclitis

11.0

307.7

858

791

M01CC01

ATC

penicillamine; oral

130.6

307.7

222

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

307.7

4868

23427

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

12.9

307.7

1469

1179

299, ,

Kela drug reimbursment

150.7

307.7

181

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

131.9

307.7

903

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

19.1

307.7

274

144

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

63.3

307.7

3587

633

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

12.1

307.7

2305

2025

M01CB01

ATC

sodium aurothiomalate; parenteral

1178.2

307.7

2310

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

108.1

307.7

291

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

420.8

307.7

1723

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

13382

96896

R4120

NOMESCO Finland

Occupational therapy

3.3

307.7

2957

9644

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

15.8

307.7

2101

1408

291

Kela drug reimbursment

Tofacitinib

1457.5

307.7

427

P01BA01

ATC

chloroquine; systemic

17.3

307.7

377

219

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

7.3

307.7

7941

13788

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

521.2

307.7

1065

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

136.8

307.7

5019

432

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

5.3

307.7

1133

2172

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

564.4

307.7

776

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

96.8

307.7

213

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

89.0

307.7

196

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

217.0

307.7

10994

767

L04AA29

ATC

[U] tofacitinib

61.6

307.7

392

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

52.6

307.7

273

L04AC13

ATC

ixekizumab; parenteral

54.8

307.7

446

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.5

307.7

1453

4291

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

18068

140286

L04AX03

ATC

methotrexate; systemic

120.9

307.7

20522

4680

S01BA04

ATC

prednisolone; ophthalmic

4.4

307.7

967

2239

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

25.2

307.7

327

130

ZX120

NOMESCO Finland

Intravenous

2.7

307.7

3737

14897

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

33.5

307.7

10746

4745

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

83.8

307.7

251

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

14081

98873

3005

Kela drug reimbursment

Tofacitinib

45.5

307.7

358

L04AA24

ATC

abatacept; parenteral

+∞

307.7

784

A05AA02

ATC

ursodeoxycholic acid; oral

10.6

307.7

1354

1325

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

35.9

307.7

1008

288

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

307.7

2753

12015

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

8.9

307.7

1013

1169

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

14.2

307.7

336

237

M05BA04

ATC

alendronic acid; oral

3.5

307.7

4169

13171

L88

ICPC

Rheumatoid/seropositive arthritis

107.9

307.7

8480

1061

M12.3

ICD-10 Finland

Palindromic rheumatism

26.8

307.7

270

101

XX9XE

NOMESCO Finland

Other ultrasound examination

30.8

307.7

1059

353

ZX140

NOMESCO Finland

Intra articular

21.1

307.7

747

360

L40.5

ICD-10 Finland

Arthropathic psoriasis

52.1

307.7

2630

546

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

185.1

307.7

222

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

258.4

307.7

712

P01BA02

ATC

hydroxychloroquine; oral

63.2

307.7

15396

4619

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

40.6

307.7

696

174

D05AX52

ATC

calcipotriol, combinations; topical

3.8

307.7

2616

7361

L04AA01

ATC

[U] ciclosporin

15.9

307.7

1304

845

L04AB04

ATC

adalimumab; parenteral

62.1

307.7

3905

711

L04AB01

ATC

etanercept; parenteral

705.5

307.7

3252

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

175.8

307.7

176

9256

FHL

Synovectomy (knee 9311)

101.3

307.7

263

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

32.0

307.7

429

135

ND1AE

NOMESCO Finland

Wrist ultrasound examination

15.6

307.7

290

186

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

59.4

307.7

196

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

82.6

307.7

394

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

6.4

307.7

753

1191

XPX04

NOMESCO Finland

Angioscopy

12.1

306.5

309

257

L04AA37

ATC

[U] baricitinib

753.4

304.9

301

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

301.8

2565

11749

A02BC03

ATC

lansoprazole; oral

1.6

301.4

8825

60131

E0000UV, ,

ATC

1.6

300.8

13260

99436

M06.3

ICD-10 Finland

Rheumatoid nodule

73.1

297.0

161

L99

ICPC

Musculoskeletal disease other

3.6

294.9

999

2810

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

69.5

292.9

160

L34

ICPC

Musculoskeletal, Blood test

132.5

288.1

146

L04AC14

ATC

sarilumab; systemic

2698.9

287.9

279

M32

ICD-10 Finland

Systemic lupus erythematosus

57.8

287.5

162

L01CB

ATC

Podophyllotoxin derivatives

705.2

285.2

282

1XC02, ,

NOMESCO Finland

8.4

284.8

374

449

L04AF03

ATC

upadacitinib; oral

18.5

283.6

226

122

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

6.3

282.4

478

761

RT310, ,

NOMESCO Finland

79.3

281.8

151

K75.4

ICD-10 Finland

Autoimmune hepatitis

19.0

281.7

222

117

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.4

279.9

720

1661

M19.2

ICD-10 Finland

Other secondary arthrosis

4.8

278.2

638

1342

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

276.9

5706

35332

NDG74

NOMESCO Finland

Fusion of first IP joint

16.1

275.4

235

146

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

275.3

4115

23141

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

33.2

274.4

176

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

273.7

7657

51364

D07AC01

ATC

betamethasone; topical

1.5

272.3

11289

82975

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.8

272.1

1483

5516

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

24.4

271.8

193

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

50.6

271.6

157

R50.9

ICD-10 Finland

Fever, unspecified

1.8

270.6

4835

28715

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

10.0

270.2

310

312

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

269.1

13477

103086

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

8.5

268.3

346

406

R4110

NOMESCO Finland

Physiotherapy

1.6

268.2

8559

59224

S01FA04

ATC

cyclopentolate; ophthalmic

5.7

267.4

508

905

J01DB01

ATC

cefalexin; oral

1.7

267.1

25883

228282

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

265.0

4348

25153

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

31.6

262.9

171

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

261.8

13299

101832

M01AX01

ATC

nabumetone; oral

2.7

259.7

1498

5733

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

259.4

2684

13264

RK210, ,

NOMESCO Finland

18.6

258.0

205

110

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

257.3

3060

15910

ZXX09

NOMESCO Finland

Extent of procedure, more than 8 units

32.7

254.8

164

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

8.1

252.7

341

423

L04AF01

ATC

tofacitinib; oral

60.7

250.6

140

NHG22

NOMESCO Finland

Fusion of subtalar joint

7.1

248.9

376

531

H26.3

ICD-10 Finland

Drug-induced cataract

7.9

248.2

342

435

9527

FHL

Alloarthroplasty, implant or endoprosthesis

115.2

247.3

127

RT171, ,

NOMESCO Finland

27.8

246.3

167

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

245.2

6725

44703

M02.8

ICD-10 Finland

Other reactive arthropathies

9.1

243.9

299

329

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

13.3

242.6

230

173

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

242.3

4303

25438

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.8

239.5

1255

4568

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.5

239.4

1614

6657

WZC30

NOMESCO Finland

Teaching

1.7

239.3

5114

31848

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

238.6

3062

16326

9272

FHL

Metatarsophalangeal joint resection

14.5

238.5

215

148

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

79.2

236.8

127

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.9

236.2

522

1064

SPAT1202

SPAT

Intra-articular injection

3.0

236.1

1105

3782

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

4.5

234.7

586

1320

TGC00

NOMESCO Finland

Bronchial lavation

3.3

234.3

934

2911

M05BX04

ATC

denosumab; parenteral

2.2

232.8

2084

9717

L04AC21

ATC

bimekizumab; systemic

44.1

230.0

137

D05AX03

ATC

calcitriol; topical

4.6

229.0

549

1197

M79.7

ICD-10 Finland

Fibromyalgia

2.6

228.0

1340

5171

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

223.4

950

3077

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

221.9

10763

80837

K71

ICPC

Rheumatic fever/heart disease

96.4

221.6

116

PAW37

NOMESCO Finland

Biopsy of temporal artery

6.7

221.5

352

525

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

12.4

221.1

219

177

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

219.6

9025

65487

M01AX17

ATC

nimesulide; oral

1.6

219.1

6944

47587

Z3226

NOMESCO Finland

Physiotherapist

1.6

217.3

5362

34584

356

Kela drug reimbursment

Nintedanib and pirfenidone

9.5

215.6

256

270

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

8.9

214.9

269

304

M01AB01

ATC

indometacin; systemic, rectal

2.1

211.8

2105

10215

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

7.1

211.8

320

452

A07EA06

ATC

budesonide; oral, local oral

2.5

209.5

1332

5339

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

4.4

208.8

527

1197

4AB02, ,

NOMESCO Finland

10.8

207.3

224

207

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

4.0

205.5

601

1525

M34.0

ICD-10 Finland

Progressive systemic sclerosis

35.7

205.4

129

UJF32

NOMESCO Finland

Coloscopy

1.5

204.6

7757

55176

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

671.7

204.1

202

L01AA01

ATC

cyclophosphamide; systemic

10.4

199.3

221

212

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

61.5

199.0

111

L01BB01, ,

ATC

16.7

198.5

166

M06.1

ICD-10 Finland

Adult-onset Still disease

44.9

197.1

117

L04AB02

ATC

infliximab; parenteral

7.6

197.0

281

372

N02BE01

ATC

paracetamol; systemic, rectal

1.7

196.2

27826

254682

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

7.7

194.9

273

354

318

Kela drug reimbursment

Teriparatide

7.3

194.0

286

393

WX204

NOMESCO Finland

Axillary plexus blockaced

2.7

193.5

1119

4280

M05BA06

ATC

ibandronic acid; systemic

3.4

190.9

715

2143

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.2

190.4

757

2354

M33.2

ICD-10 Finland

Polymyositis

16.7

190.0

159

ZZH31

NOMESCO Finland

Bone allograft, small pieces

5.5

189.6

367

665

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.6

187.6

637

1792

A02BC01

ATC

omeprazole; systemic

1.5

187.1

7921

57457

284

Kela drug reimbursment

Nintedanib and pirfenidone

8.5

186.5

240

281

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

31.8

186.2

121

M05BA01

ATC

etidronic acid; systemic

7.4

185.9

270

365

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.8

185.8

428

903

7143D

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]

611.3

185.4

184

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

29.2

184.4

123

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

183.4

3249

19084

ND2CG

NOMESCO Finland

Extensive MRI of hand

10.0

183.0

209

N03AX16

ATC

[U] pregabalin

1.5

182.9

6727

47358

S18

ICPC

Laceration/cut

1.4

182.7

13862

111905

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

52.3

182.7

105

SBA10

NOMESCO Finland

Measurement of salivary flow rate

4.6

181.1

433

942

K07.60

ICD-10 Finland

Snapping jaw

2.1

180.2

1724

8231

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

4.4

179.2

452

1026

NDG76

NOMESCO Finland

Fusion of DIP joint

5.0

178.8

386

771

L04AC16

ATC

guselkumab; systemic

14.2

177.5

162

114

M79.6

ICD-10 Finland

Pain in limb

1.4

177.3

13415

108055

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

175.8

2546

14059

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

175.3

1449

6521

H05AA02

ATC

teriparatide; parenteral

7.2

174.3

260

362

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

14.0

174.1

160

114

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

173.9

3177

18812

D07AD01

ATC

clobetasol; topical

1.6

173.4

5077

33930

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

172.5

2168

11426

A02BC05

ATC

esomeprazole; systemic

1.4

171.9

11987

95047

NF1DA

NOMESCO Finland

X-ray of hips

3.1

171.7

753

2481

WX320

NOMESCO Finland

Spinalanesthesy

1.5

171.6

7076

50902

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

171.3

1627

7743

NHG82

NOMESCO Finland

Fusion of other tarsal joint

4.5

170.3

425

957

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

169.1

2261

12161

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

40.7

167.9

102

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

167.8

4648

30641

9283

FHL

Subtalar joint ossification surgery (or triple)

25.0

167.7

118

M02.3

ICD-10 Finland

Reiter disease

19.6

167.6

130

M16.7

ICD-10 Finland

Other secondary coxarthrosis

5.1

167.4

356

702

9289

FHL

Other measure in this category

24.8

165.8

117

L40

ICD-10 Finland

Psoriasis

3.2

165.7

688

2195

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

15.4

165.3

144

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

164.9

1411

6440

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.6

164.3

1008

3966

L95

ICPC

Osteoporosis

2.3

163.0

1317

5869

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

162.6

6758

48608

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.5

162.6

1060

4293

J01MA12

ATC

levofloxacin; systemic

1.6

161.7

5114

34724

Z3231

NOMESCO Finland

Registered nurse

1.5

160.6

7708

56994

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.7

159.2

854

3141

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

50.9

159.2

7168A

ICD-9 Finland

Other and unspecified arthropathies, Other specified arthropathy

41.6

158.8

L04AC05

ATC

ustekinumab; parenteral

6.5

158.5

261

404

L40.8

ICD-10 Finland

Other psoriasis

4.9

156.7

350

720

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

156.3

2830

16687

9531

FHL

Arthrodesis of the hand joint

8.7

155.9

198

228

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.9

154.7

2083

11219

A02BB01

ATC

misoprostol; oral

6.2

154.6

263

421

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

154.3

2097

11329

L17

ICPC

Foot/toe symptom/complaint

1.4

154.1

9156

70267

RT231, ,

NOMESCO Finland

65.1

153.7

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

11.5

153.4

159

138

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.6

153.3

510

1415

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.7

153.2

3153

19255

ZXX08

NOMESCO Finland

Extent of procedure, 8 units

26.8

153.0

105

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

152.4

3065

18602

ZXA00

NOMESCO Finland

Right side

1.5

152.3

7161

52653

N03AX12

ATC

[U] gabapentin; oral

1.6

151.6

4602

30913

M31.1

ICD-10 Finland

Thrombotic microangiopathy

22.8

151.0

110

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

150.7

2026

10905

J01MA02

ATC

ciprofloxacin; systemic

1.4

150.0

10931

86744

M02.1

ICD-10 Finland

Postdysenteric arthropathy

9.8

149.7

173

176

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.5

148.9

532

1547

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

13.5

147.9

139

103

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

147.8

2121

11655

71599

ICD-8 Finland

Arthritis, unspecified

8.7

147.8

188

217

C03CA01

ATC

furosemide; systemic

1.4

146.7

7965

60058

A07EC02

ATC

mesalazine; oral, rectal

2.0

145.3

1604

8065

E000001, ,

ATC

1.5

145.1

5590

39475

B01AB05

ATC

enoxaparin; parenteral

1.4

144.7

8899

68539

7165A

ICD-9 Finland

Other and unspecified arthropathies, Unspecified polyarthropathy or polyarthritis

38.5

144.5

A02BA02

ATC

ranitidine; systemic

1.5

144.3

5208

36281

M33.1

ICD-10 Finland

Other dermatomyositis

20.5

143.2

109

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.6

143.1

845

3262

R06.0

ICD-10 Finland

Dyspnoea

1.4

143.0

7751

58379

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

142.9

3404

21567

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

13.5

142.8

134

C08CA05

ATC

nifedipine; systemic

2.0

142.8

1693

8730

SPAT1153

SPAT

Removal of sutures

1.4

142.8

8591

65891

9260

FHL

Alloarthroplasty, endoprosthesis or implant

76.7

142.7

M81.4

ICD-10 Finland

Drug-induced osteoporosis

6.6

142.5

231

352

J01CA04

ATC

amoxicillin; systemic

1.4

142.4

24849

225586

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

141.4

1656

8501

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.7

141.2

803

3042

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

14.3

141.2

128

M25.4

ICD-10 Finland

Effusion of joint

3.4

140.9

516

1524

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

140.5

4102

27272

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

140.1

11086

88873

L93.0

ICD-10 Finland

Discoid lupus erythematosus

6.0

140.0

247

410

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

139.4

11404

91879

RT350, ,

NOMESCO Finland

15.7

139.1

120

D07AC13

ATC

mometasone; topical

1.4

138.2

8158

62294

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

47.5

138.0

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

7.2

137.7

205

285

NHG20

NOMESCO Finland

Fusion of talocrural joint

5.3

137.4

280

532

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

43.0

136.7

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

136.3

1214

5625

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.3

135.8

1027

4445

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

11.4

135.6

141

123

S01FA02

ATC

scopolamine; ophthalmic

4.5

135.0

333

743

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

40.8

135.0

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

134.5

2966

18412

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

134.1

1414

6988

L04AF02

ATC

baricitinib; oral

+∞

134.1

129

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

12.0

134.1

135

112

K51.5

ICD-10 Finland

Left sided colitis

2.5

133.6

848

3389

NHF80

NOMESCO Finland

Operation for debridement of toe joint, open

19.0

133.5

105

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

10.5

133.3

147

140

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

20.5

132.8

101

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

132.6

2152

12268

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

5.7

132.5

246

429

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

132.2

6191

45302

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

131.8

10803

86852

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

8.1

131.5

177

219

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.1

131.4

563

1830

D06BB04

ATC

podophyllotoxin; topical

2.0

131.3

1401

6953

J01FA06

ATC

roxithromycin; oral

1.4

131.3

11203

90608

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.3

130.7

1034

4562

D05BB02

ATC

acitretin; oral

2.7

130.5

728

2731

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

8.8

130.2

164

187

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

129.2

8400

65044

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.7

129.1

691

2538

S97

ICPC

Chronic ulcer skin

1.9

128.6

1765

9549

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

16.6

128.5

108

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

128.5

1110

5079

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

128.1

1809

9877

D05AA

ATC

Tars

5.6

127.1

244

439

RT274, ,

NOMESCO Finland

12.5

127.0

125

100

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

126.7

1329

6554

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

126.6

6633

49478

RJ410, ,

NOMESCO Finland

7.3

126.5

186

255

286

Kela drug reimbursment

Ciclosporin eye drop

27.6

126.5

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

25.8

126.4

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

126.0

776

3057

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.8

125.6

652

2356

NC1AE

NOMESCO Finland

Elbow ultrasound examination

12.2

125.5

125

102

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

6.3

125.1

212

338

M02AA07

ATC

piroxicam; topical

1.4

125.1

9883

78843

ZXE00

NOMESCO Finland

One hour or less

1.3

124.8

10797

87321

L01EX09

ATC

nintedanib; oral

9.9

124.6

143

144

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.2

124.6

491

1518

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

163.3

124.1

131

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

12.1

123.8

124

102

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

31.0

123.6

ZXA05

NOMESCO Finland

Left side

1.4

123.5

6527

48728

L12

ICPC

Hand/finger symptom/complaint

1.5

123.2

5064

36088

J01AA02

ATC

doxycycline; systemic

1.4

123.2

23082

208536

M08.8

ICD-10 Finland

Other juvenile arthritis

251.7

122.7

126

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

144.1

121.9

130

I73.0

ICD-10 Finland

Raynaud syndrome

2.9

121.4

600

2112

M35.7

ICD-10 Finland

Hypermobility syndrome

3.2

121.2

493

1554

M05.2

ICD-10 Finland

Rheumatoid vasculitis

36.0

121.1

H20

ICD-10 Finland

Iridocyclitis

5.6

121.0

232

417

A01

ICPC

Pain general/multiple sites

1.6

120.3

2977

18991

Z2221

NOMESCO Finland

Medical doctor

1.4

120.3

7545

57952

K76.9

ICD-10 Finland

Liver disease, unspecified

3.2

119.2

471

1459

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

10.3

119.1

133

129

L28

ICPC

Limited function/disability (L)

1.5

119.0

5226

37687

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

118.7

8362

65411

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

118.6

1078

5032

RJ511, ,

NOMESCO Finland

10.9

118.5

127

116

S01XA18

ATC

ciclosporin; ophthalmic

4.1

117.5

325

792

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

117.5

9710

77810

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

6.0

117.2

207

344

L11

ICPC

Wrist symptom/complaint

1.6

117.0

2754

17348

J05AB11

ATC

valaciclovir; oral

1.5

116.5

4145

28666

RJ421, ,

NOMESCO Finland

6.9

115.5

178

257

A46

ICD-10 Finland

Erysipelas

1.5

115.5

3930

26925

J01DA01

ATC

[U] cefalexin

1.3

115.4

17751

155046

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

114.9

1440

7556

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

114.9

5445

39796

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.5

114.8

765

3127

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

114.8

1009

4647

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

114.7

6163

46058

WW200

NOMESCO Finland

Immunization

2.4

114.6

825

3492

7102B

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]

37.2

114.1

R1250

NOMESCO Finland

Evaluation of functional capability

2.4

113.9

778

3216

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.0

112.4

1244

6251

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

111.6

2290

13920

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

111.5

7217

55596

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

5.0

111.3

238

472

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

111.2

7736

60271

RS221, ,

NOMESCO Finland

3.1

111.2

465

1490

3641A

ICD-9 Finland

Disorders of iris and ciliary body, Chronic iridocyclitis

39.8

111.2

R03AC02

ATC

salbutamol; inhalant

1.3

110.6

16029

138519

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

7.2

110.6

165

230

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

110.3

2997

19527

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

8.3

109.1

144

174

N06AA09

ATC

amitriptyline; systemic

1.6

108.5

2591

16364

R5120

NOMESCO Finland

Preparation of an aid

2.3

107.9

821

3560

RT172, ,

NOMESCO Finland

13.4

107.3

101

H02AB09

ATC

hydrocortisone; systemic

2.4

106.9

724

2981

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

106.7

3478

23582

SPAT1229

SPAT

Assessment of need for aid

1.7

106.4

2016

11988

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.5

106.4

692

2797

4AA12, ,

NOMESCO Finland

7.4

105.8

153

206

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.9

105.8

1461

7911

RF120, ,

NOMESCO Finland

3.4

105.2

380

1113

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

104.6

7087

54895

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

4.6

104.2

247

534

M01AB05

ATC

diclofenac; systemic, rectal

1.3

104.2

19088

169474

7143B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]

+∞

103.9

100

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

103.6

3651

25154

TEG00

NOMESCO Finland

Punction of mandibular joint

12.0

103.5

104

9314

FHL

Total knee endoprosthesis (also includes patellar part)

7.6

103.4

147

194

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

102.8

10983

90830

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

123.0

102.7

111

S01BA07

ATC

fluorometholone; ophthalmic

2.8

102.5

509

1797

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

5.7

102.5

192

338

SPAT1263

SPAT

Sampling

1.3

102.3

11597

96650

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

20.4

102.3

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.3

102.0

813

3596

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

8.4

101.9

132

156

RF410, ,

NOMESCO Finland

3.3

101.7

390

1186

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

6.5

101.2

165

253

J05AB01

ATC

aciclovir; systemic

1.4

101.1

6127

46579

RJ411, ,

NOMESCO Finland

5.2

100.7

209

404

L04AX05

ATC

pirfenidone; oral

7.7

100.3

140

181

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

6.8

99.8

157

232

RT160, ,

NOMESCO Finland

14.5

99.7

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

99.3

19679

175914

M06.2

ICD-10 Finland

Rheumatoid bursitis

45.2

99.3

0108, ,

NOMESCO Finland

48.1

98.9

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

98.9

953

4548

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

5.5

98.7

192

350

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

98.7

702

2956

H15.1

ICD-10 Finland

Episcleritis

2.8

98.6

498

1774

QDH05

NOMESCO Finland

Correction of deformity of toe nail

6.6

98.2

157

236

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

14.3

98.0

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

3.7

97.2

313

850

M01AB08

ATC

etodolac; oral

1.7

96.7

1918

11538

R2110

NOMESCO Finland

Giving the first information

1.7

96.2

1881

11274

R3130

NOMESCO Finland

Training in activities of daily lining

29.0

95.5

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

33.7

95.3

J01FA10

ATC

azithromycin; systemic

1.3

95.2

16568

145312

R60.0

ICD-10 Finland

Localized oedema

1.5

95.1

3459

23955

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

94.8

3313

22755

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

94.4

8828

71481

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

6.3

94.4

158

249

NGF10

NOMESCO Finland

Total synovectomy of knee, open

10.1

94.4

107

106

H30.2

ICD-10 Finland

Posterior cyclitis

6.6

94.1

152

231

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

94.1

778

3494

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.4

93.9

340

998

RJ512, ,

NOMESCO Finland

10.0

93.8

107

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

33.2

93.3

RF420, ,

NOMESCO Finland

3.0

92.9

424

1429

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

92.9

1781

10615

NDG71

NOMESCO Finland

Arthrodes of first MP joint

6.4

92.2

153

239

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

10.3

92.2

103

100

4AC07, ,

NOMESCO Finland

191.3

92.1

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

161.1

91.9

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

91.9

1150

6026

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

91.8

819

3793

H57.1

ICD-10 Finland

Ocular pain

1.9

91.1

1147

6021

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

18.9

91.1

NH1AD

NOMESCO Finland

Ankle and foot CT

2.3

91.0

704

3075

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

90.5

1018

5141

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.6

90.5

546

2129

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

6.1

90.3

156

254

A04AA01

ATC

ondansetron; systemic, rectal

1.6

89.9

2295

14702

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

89.8

2756

18409

NHF15

NOMESCO Finland

Synovectomy of ankle, arthroscopic

8.6

89.8

115

134

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.8

89.6

449

1593

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

89.6

6244

48396

K50.8

ICD-10 Finland

Other Crohn disease

2.8

89.5

463

1671

L84

ICD-10 Finland

Corns and callosities

2.0

89.5

976

4876

M46.0

ICD-10 Finland

Spinal enthesopathy

9.4

89.2

106

112

M31.6

ICD-10 Finland

Other giant cell arteritis

6.4

88.9

148

232

WX002

NOMESCO Finland

Sedation and analgesia

1.4

88.8

4955

37065

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

8.6

88.6

113

131

ND2BG

NOMESCO Finland

MRI of hand

6.2

88.3

150

240

RJ190, ,

NOMESCO Finland

8.3

87.7

115

138

SPAT1325

SPAT

Vaccination

1.3

87.4

8673

70633

L16

ICPC

Ankle symptom/complaint

1.5

87.4

3334

23281

B02.9

ICD-10 Finland

Zoster without complication

1.7

87.2

1858

11383

N06AX21

ATC

duloxetine; oral

1.5

87.1

3325

23220

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

86.9

2177

13880

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.8

86.9

196

407

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.4

86.6

626

2655

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

86.4

956

4799

M02AA10

ATC

ketoprofen; topical

1.4

86.2

4269

31275

J01MA14

ATC

moxifloxacin; systemic

1.6

86.0

2305

14931

SPAT1255

SPAT

Intravenous administration of medicine

1.7

85.5

1712

10318

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.5

85.4

542

2166

K02.1

ICD-10 Finland

Caries of dentine

1.3

85.4

16946

150079

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.0

85.2

1006

5167

Z50.1

ICD-10 Finland

Other physical therapy

1.8

85.1

1408

8048

UJK12

NOMESCO Finland

Peroral cholangioscopy

6.7

84.8

134

199

SFA10

NOMESCO Finland

One-surface restoration

1.3

84.3

15760

138509

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.8

84.2

1271

7067

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.7

84.2

450

1652

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

83.4

14853

129744

M31.7

ICD-10 Finland

Microscopic polyangiitis

12.0

83.2

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

16.1

83.2

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

82.7

3733

50103

5BA08, ,

NOMESCO Finland

4.8

82.5

187

390

ACC51

NOMESCO Finland

Release of median nerve

1.6

82.4

2068

13188

E000002, ,

ATC

1.5

82.3

2859

19580

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

5.8

81.8

150

259

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

81.8

1968

12423

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

81.5

3399

24121

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

4.4

81.1

205

467

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

81.1

20933

190561

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

81.0

1287

7267

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

80.8

14434

125943

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

31.0

80.7

N02AC04

ATC

dextropropoxyphene; oral

2.0

80.7

891

4470

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

5.1

80.6

169

330

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

80.5

6088

47649

N02AA05

ATC

oxycodone; systemic

1.4

80.4

4609

34574

ZXA10

NOMESCO Finland

Bilateral

1.4

80.2

4760

35900

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

80.2

1905

11986

M54.5

ICD-10 Finland

Low back pain

1.3

80.1

10335

86789

M15.3

ICD-10 Finland

Secondary multiple arthrosis

5.5

80.1

154

278

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.3

79.7

590

2528

4AA24, ,

NOMESCO Finland

122.4

79.7

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.3

79.7

310

952

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

79.7

5002

38062

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

3.3

79.6

301

908

ZY010

NOMESCO Finland

Hospital outpatient

1.8

79.2

1337

7683

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

78.9

1069

5746

SPAT1301

SPAT

No procedures

1.3

78.9

8290

67829

M43.3

ICD-10 Finland

Recurrent atlantoaxial subluxation with myelopathy

20.6

78.9

M31.0

ICD-10 Finland

Hypersensitivity angiitis

20.6

78.9

K51.8

ICD-10 Finland

Other ulcerative colitis

2.8

78.7

413

1502

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

14.1

78.5

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

6.3

78.5

131

206

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

17.0

78.4

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

78.2

1369

7949

WZA00

NOMESCO Finland

Concise certificate

1.6

78.1

1747

10827

I77.6

ICD-10 Finland

Arteritis, unspecified

7.0

78.1

119

170

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

22.7

77.9

Z71.8

ICD-10 Finland

Other specified counselling

1.3

77.3

9614

80286

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.3

77.2

600

2625

Z2446

NOMESCO Finland

Social worker

1.7

76.4

1622

9919

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

76.4

690

3211

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

6.8

76.0

119

175

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

14.3

76.0

L15

ICPC

Knee symptom/complaint

1.3

75.5

7020

56468

TEA00

NOMESCO Finland

Biopsy of lip

3.1

75.5

313

999

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

75.4

9996

84049

71490

ICD-8 Finland

Other specified forms of arthritis, Arthritis postinfectiosa NUD

6.5

75.3

122

186

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

75.2

817

4074

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.3

75.0

283

853

D07AB08

ATC

desonide; topical

1.5

74.9

2819

19598

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

74.7

855

4344

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

74.6

7809

63770

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

74.2

5069

39024

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.6

73.6

246

686

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

2.1

73.5

683

3213

1008, ,

NOMESCO Finland

9.6

73.5

RS222, ,

NOMESCO Finland

2.9

73.4

346

1188

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

73.0

2609

17953

M03BX02

ATC

tizanidine; oral

1.2

72.6

17772

159710

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

5.1

72.5

154

304

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.5

72.4

445

1752

E000003, ,

ATC

1.8

72.2

1114

6234

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

2.8

72.0

367

1315

L08

ICPC

Shoulder symptom/complaint

1.3

71.8

6267

49929

UJF92

NOMESCO Finland

Capsular endoscopy

2.2

71.1

603

2736

N02BF01

ATC

gabapentin; oral

1.5

70.8

2808

19711

NHQ40

NOMESCO Finland

Amputation of toe

2.6

70.8

419

1620

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

3.6

70.7

238

667

C08CA01

ATC

amlodipine; oral

1.3

70.6

9974

84319

Z01.2

ICD-10 Finland

Dental examination

1.2

70.6

13303

116103

M48.0

ICD-10 Finland

Spinal stenosis

1.4

70.5

3072

21944

J02AC01

ATC

fluconazole; systemic

1.2

70.5

11200

95947

NDL40

NOMESCO Finland

Repair of tendon of finger with transplant

5.5

70.3

136

247

NDG63

NOMESCO Finland

Arthroplasty of II-V MCP joint

36.5

70.1

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

2.5

70.0

449

1804

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

69.9

525

2265

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.3

69.8

548

2408

M46

ICD-10 Finland

Other inflammatory spondylopathies

30.5

69.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

69.3

20969

192295

P01AB01

ATC

metronidazole; oral, rectal

1.2

69.1

11113

95265

M25.9

ICD-10 Finland

Joint disorder, unspecified

2.9

68.9

324

1111

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

68.9

2161

14467

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

27.5

68.8

JJC00

NOMESCO Finland

Allogenic transplantation of liver

6.3

68.5

115

182

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.8

68.4

1153

6621

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

5.9

68.2

123

209

H26.2

ICD-10 Finland

Complicated cataract

2.7

68.1

362

1326

C10AC01

ATC

colestyramine; oral

2.0

68.1

767

3875

Z94.4

ICD-10 Finland

Liver transplant status

5.1

68.0

143

280

A07AA02

ATC

nystatin; oral

1.6

67.8

1499

9257

NH1DG

NOMESCO Finland

Ankle and foot very extensive MRI examination with high intensity magnet

6.2

67.8

115

184

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

67.6

854

4486

M01AE52

ATC

naproxen and esomeprazole; oral

1.9

67.6

835

4354

L04AC18

ATC

risankizumab; parenteral

6.5

67.5

110

169

NDG20

NOMESCO Finland

Fusion of wrist, partial

4.0

67.4

189

466

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

67.3

2988

21403

C07AB07

ATC

bisoprolol; oral

1.2

67.2

12743

111085

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

67.1

3667

27224

36402

ICD-8 Finland

Iritis, Iridocyclitis, uveitis chronica

12.7

66.8

R05

ICD-10 Finland

Cough

1.3

66.8

5821

46306

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

6.6

66.5

106

159

TNF10

NOMESCO Finland

Puncture of hip joint

6.8

66.5

104

153

NCF15

NOMESCO Finland

Synovectomy of elbow joint, arthroscopic

16.4

66.2

RJ412, ,

NOMESCO Finland

7.2

66.1

136

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

7.7

65.9

119

L01XE31

ATC

[U] nintedanib

8.7

65.8

-1, ,

NOMESCO Finland

1.3

65.6

8746

73301

SFA20

NOMESCO Finland

Two-surface restoration

1.2

65.1

16576

148757

7143X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS NUD]

222.3

65.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

65.0

3339

24525

7118L

ICD-9 Finland

Arthropathy associated with infections, Arthropathy associated with other infectious and parasitic diseases[ARTHRITIS POSTINFECTIOSA ALIA, USEAT NIVELET]

13.9

65.0

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

64.9

3718

27799

NBF15

NOMESCO Finland

Humeroscapular synovectomy, arthroscopic

5.8

64.1

116

198

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

5.0

64.0

136

269

13603

ICD-8 Finland

Other and unspecified infective and parasitic diseases, Morbus Reiter, syndroma urethro-oculo-articularis

19.1

63.6

RF212, ,

NOMESCO Finland

5.0

63.3

137

275

A03

ICPC

Fever

1.3

63.0

4570

35403

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

62.7

1680

10860

L88

ICD-10 Finland

Pyoderma gangrenosum

6.1

62.6

109

179

RK250, ,

NOMESCO Finland

4.3

62.3

162

378

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

2.9

62.2

291

996

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

62.1

1358

8362

R06AE07

ATC

cetirizine; oral

1.2

61.9

12282

107257

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

2.5

61.9

389

1548

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

61.6

1449

9081

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

61.4

2169

14869

M79.1

ICD-10 Finland

Myalgia

1.3

61.3

3986

30373

A01AB09

ATC

miconazole; local oral

1.5

61.3

2164

14831

SFA30

NOMESCO Finland

Three-surface restoration

1.2

61.2

11534

100161

SPAT1204

SPAT

Arthrocentesis

3.4

61.2

225

668

M01AC01

ATC

piroxicam; systemic, rectal

1.4

61.0

3202

23585

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

4.3

61.0

156

359

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

25.2

61.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

60.9

10207

87554

M81.8

ICD-10 Finland

Other osteoporosis

2.9

60.9

297

1040

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

60.8

657

3270

J01FA09

ATC

clarithromycin; systemic

1.2

60.3

8310

69764

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

60.3

3368

25062

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

59.9

3321

24679

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.4

59.9

409

1692

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

59.7

1676

10945

R05

ICPC

Cough

1.3

59.6

6814

55975

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

59.6

4318

33423

M02

ICD-10 Finland

Reactive arthropathies

9.2

59.5

L29

ICPC

Musculoskeletal sympt/complt other

1.5

59.5

2359

16534

E000006, ,

ATC

1.5

59.3

1697

11129

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

59.3

5557

44538

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

3.4

59.1

211

615

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.1

59.0

588

2842

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

6.9

58.9

132

RJ210, ,

NOMESCO Finland

6.0

58.9

103

170

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

58.9

5001

39559

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

58.8

648

3249

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

58.7

1791

11910

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

58.7

4715

37019

D05AX05

ATC

tazarotene; topical

7.4

58.6

115

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

58.6

15453

138512

D02AE01

ATC

carbamide; topical

1.6

58.5

1566

10118

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

58.3

733

3845

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

13.3

58.2

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.0

58.2

257

852

S20

ICPC

Corn/callosity

2.1

58.1

535

2510

M11.2

ICD-10 Finland

Other chondrocalcinosis

4.5

58.0

140

308

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

57.9

1333

8309

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

57.9

4872

38481

R5110, ,

SPAT

1.5

57.8

2208

15361

M01AH03

ATC

valdecoxib; oral

1.6

57.7

1489

9539

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

19.5

57.6

Z22.30

ICD-10 Finland

Latent tuberculosis

12.3

57.6

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

57.5

2616

18796

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

57.5

6500

53287

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.4

57.4

412

1743

R51.80

ICD-10 Finland

Headache

1.3

57.3

4139

32003

9273

FHL

Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe

3.0

57.1

251

830

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

57.1

1142

6871

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

57.0

1424

9052

M35

ICD-10 Finland

Other systemic involvement of connective tissue

11.8

56.9

SBB10

NOMESCO Finland

Dental impressions

1.5

56.9

1655

10889

H16.0

ICD-10 Finland

Corneal ulcer

1.6

56.2

1215

7457

NDM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand

3.6

56.0

187

522

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.2

55.8

489

2250

NHF70

NOMESCO Finland

Operation for debridement of joint of foot, open

14.6

55.7

M35.2

ICD-10 Finland

Behçet disease

13.6

55.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

55.6

3050

22608

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

55.6

954

5503

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

55.6

26997

256792

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

55.4

1714

11426

RF210, ,

NOMESCO Finland

1.9

55.3

690

3611

J04AB02

ATC

rifampicin; systemic

2.6

55.3

332

1294

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

55.1

1590

10441

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

54.8

1579

10369

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.2

54.6

214

661

M03.2*A04.6

ICD-10 Finland

Postinfectious arthropathy in enteritis due to Yersinia enterocolitica

24.2

54.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

54.1

3967

30717

M40.5

ICD-10 Finland

Lordosis, unspecified

20.4

53.5

NDG79

NOMESCO Finland

Other excision, reconstruction or fusion of joint of II-V finger

7.1

53.5

112

N02BF02

ATC

pregabalin; oral

1.5

53.3

1753

11836

SFA00

NOMESCO Finland

Small restoration

1.3

53.2

3609

27629

M05BX03

ATC

strontium ranelate; oral

3.5

53.2

186

535

M94.1

ICD-10 Finland

Relapsing polychondritis

13.0

53.2

7250A

ICD-9 Finland

Polymyalgia rheumatica[POLYMYALGIA RHEUMATICA]

13.4

53.1

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

53.1

1196

7415

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.3

53.0

416

1830

E000007, ,

ATC

1.6

52.7

1328

8458

RS121, ,

NOMESCO Finland

3.4

52.5

191

564

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

19.4

52.4

XQ848

NOMESCO Finland

Dermatological photography

1.8

52.1

736

4008

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

52.1

848

4820

QDH

NOMESCO Finland

Operations on toe nails

9.3

51.9

SPAT1310

SPAT

Counselling related to known health issue

1.2

51.8

8130

68979

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

51.8

811

4556

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.0

51.7

562

2804

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.3

51.7

405

1780

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.2

51.4

440

2006

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

51.2

3242

24556

NXL00

NOMESCO Finland

Biopsy of muscle

4.3

51.2

130

298

M34

ICD-10 Finland

Systemic sclerosis

20.4

50.9

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.5

50.9

325

1304

9269

FHL

Other measure in this category

6.4

50.8

131

7166A

ICD-9 Finland

Other and unspecified arthropathies, Unspecified monoarthritis

10.0

50.8

RJ420, ,

NOMESCO Finland

4.2

50.6

133

313

RK120, ,

NOMESCO Finland

4.8

50.6

115

241

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

2.5

50.6

312

1232

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

50.6

1907

13226

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

50.6

2299

16501

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

8.8

50.5

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.7

50.4

157

418

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.5

50.4

1561

10405

M01AA01

ATC

phenylbutazone; systemic, rectal

16.7

50.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

50.0

4666

37284

SAA04

NOMESCO Finland

Special examination of mouth

1.6

49.9

1275

8144

M05.1

ICD-10 Finland

Rheumatoid lung disease

71.1

49.9

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.7

49.7

927

5472

M60.9

ICD-10 Finland

Myositis, unspecified

3.5

49.6

173

497

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

3.0

49.5

214

701

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

2.4

49.4

354

1497

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

49.4

3096

23411

M15.4

ICD-10 Finland

Erosive (osteo)arthrosis

3.0

49.1

215

710

NHK68

NOMESCO Finland

Shortening or lengthening osteotomy of ankle or foot

4.0

49.0

137

338

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.7

49.0

154

413

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

48.9

1708

11669

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.2

48.8

409

1849

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.7

48.6

880

5154

A28

ICPC

Limited function/disability NOS

1.3

48.5

4225

33448

NB1AD

NOMESCO Finland

Shoulder CT examination

2.1

48.5

439

2047

S01BC03

ATC

diclofenac; ophthalmic

2.0

48.5

546

2760

L01BB02

ATC

mercaptopurine; oral

2.5

48.4

309

1240

NHF10

NOMESCO Finland

Synovectomy of ankle, open

20.4

48.3

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.6

48.3

284

1096

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

48.3

898

5298

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

48.2

8197

70016

H15.0

ICD-10 Finland

Scleritis

3.9

48.1

139

351

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

48.1

12575

111832

B01AB04

ATC

dalteparin; parenteral

1.6

48.1

1237

7915

WX290

NOMESCO Finland

Other blockage of nerve

1.2

48.0

12842

114429

B07.9

ICD-10 Finland

Verruca simplex

1.7

47.2

923

5519

L03

ICPC

Low back symptom/complaint

1.2

47.2

7887

67224

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

5.2

47.2

183

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.3

47.2

344

1467

J01DA09

ATC

[U] cefadroxil

1.2

47.1

6722

56371

L04AD02

ATC

tacrolimus; systemic

2.6

46.9

278

1077

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.6

46.8

992

6057

ZXD05

NOMESCO Finland

Urgent procedure

1.2

46.8

7517

63805

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

46.7

6231

51870

NBB10

NOMESCO Finland

Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified

3.4

46.6

166

484

-50

ICPC

Medication/prescr/renewal

1.7

46.5

918

5503

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

46.2

5727

47277

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.4

46.2

2110

15149

M09.0*L40.5

ICD-10 Finland

Juvenile arthritis in psoriasis

59.7

46.1

M95.8

ICD-10 Finland

Other specified acquired deformities of musculoskeletal system

11.4

46.0

134

Kela drug reimbursment

General erythroderma

4.4

45.9

116

265

S01FA06

ATC

tropicamide; ophthalmic

6.7

45.7

107

TNX10, ,

SPAT

2.7

45.6

251

938

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.8

45.4

698

3900

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

45.4

2261

16471

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

6.5

45.4

114

J47

ICD-10 Finland

Bronchiectasis

2.1

45.1

433

2065

R52.9

ICD-10 Finland

Pain, unspecified

1.4

45.1

2687

20148

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

3.9

45.0

131

333

R11

ICD-10 Finland

Nausea and vomiting

1.4

45.0

2196

15945

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

4.4

45.0

111

249

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.0

45.0

526

2694

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

44.9

2129

15383

J99.0

ICD-10 Finland

Rheumatoid lung disease

228.8

44.8

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

3.1

44.8

190

616

9477

FHL

Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)

4.0

44.7

126

313

L04AC03

ATC

anakinra; parenteral

119.4

44.6

M66.2

ICD-10 Finland

Spontaneous rupture of extensor tendons

4.8

44.5

100

208

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

44.4

1369

9115

R02

ICPC

Shortness of breath/dyspnoea

1.3

44.4

3463

26994

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.2

44.3

382

1748

RF421, ,

NOMESCO Finland

3.3

44.2

167

505

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

44.2

496

2505

L60

ICPC

Musculoskeletal, Result test/procedure

4.6

44.1

103

221

SPAT1260

SPAT

Consultation of another employee

1.3

43.7

4336

34849

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.2

43.6

386

1784

NCK10

NOMESCO Finland

Partial or total excision of bone of elbow or forearm, other location

6.8

43.5

100

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

4.3

43.4

110

252

71498

ICD-8 Finland

Other specified forms of arthritis, Alia definita

7.8

43.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

43.3

1550

10637

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

43.2

6919

58622

1222

FHL

Arthroscopy and synovial surgery

2.6

43.1

243

919

NDL99

NOMESCO Finland

Other operation on muscle or tendon of wrist or hand

4.7

43.0

206

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

4.4

42.7

107

243

SPAT1251

SPAT

Organisation of medication

1.7

42.7

776

4551

NDB70

NOMESCO Finland

Prosthetic replacement of one IP joint

9.6

42.6

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

42.5

11270

100007

L40.4

ICD-10 Finland

Guttate psoriasis

3.4

42.4

152

445

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

42.4

4263

34309

NH1CM

NOMESCO Finland

Ankle and foot extensive MRI examination with 3 Tesla magnet

5.3

42.2

157

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

42.0

1407

9528

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

42.0

2612

19704

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

41.9

1900

13616

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

2.1

41.9

390

1839

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.0

41.8

449

2233

NH3CG

NOMESCO Finland

Extensive MRI of foot

2.8

41.5

205

724

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

41.5

595

3256

QDB10, ,

SPAT

1.8

41.2

612

3385

1220

FHL

Arthroscopy

1.7

41.2

853

5176

RF430, ,

NOMESCO Finland

4.8

40.8

192

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

40.7

1514

10464

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

40.7

881

5408

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.0

40.6

433

2148

4AB0X, ,

NOMESCO Finland

109.5

40.6

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

40.6

5662

47256

H20.8

ICD-10 Finland

Other iridocyclitis

3.3

40.5

153

463

J20

ICD-10 Finland

Acute bronchitis

1.3

40.5

2628

19942

H16.9

ICD-10 Finland

Keratitis, unspecified

2.0

40.5

427

2109

H221, M084,

ICD-10 Finland

+∞

40.5

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

40.5

6851

58304

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.7

40.5

762

4511

GX1K5

NOMESCO Finland

Diffusion capacity

3.0

40.4

183

617

M30.0

ICD-10 Finland

Polyarteritis nodosa

6.1

40.3

115

TQW40, ,

SPAT

1.3

40.3

2469

18580

M50.8

ICD-10 Finland

Other cervical disc disorders

3.2

40.2

156

480

M04AA01

ATC

allopurinol; systemic

1.3

40.2

2731

20863

L13

ICPC

Hip symptom/complaint

1.2

40.1

5014

41347

M77.9

ICD-10 Finland

Enthesopathy, unspecified

1.7

40.1

749

4424

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.4

40.1

266

1088

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

40.0

1400

9565

M07.2

ICD-10 Finland

Psoriatic spondylitis

65.3

39.9

R01AD09

ATC

mometasone; nasal

1.2

39.8

12363

110956

R4110, ,

SPAT

1.3

39.7

3424

27014

R01AD08

ATC

fluticasone; nasal

1.2

39.7

7383

63385

SPAT1216

SPAT

Assessment of functional ability

1.3

39.6

3587

28484

JN4AD

NOMESCO Finland

Body CT examination

1.3

39.5

2701

20652

L01

ICPC

Neck symptom/complaint

1.3

39.5

4221

34194

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

39.4

2706

20703

4AB0M, ,

NOMESCO Finland

51.9

39.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

39.3

6819

58146

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

39.2

4988

41204

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

7.4

39.0

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.1

38.9

352

1642

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

3.2

38.8

152

471

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

38.8

1076

7003

M08

ICD-10 Finland

Juvenile arthritis

198.9

38.7

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

38.4

2996

23323

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

38.4

748

12005

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

38.3

3039

23711

78739

ICD-8 Finland

Symptoms referable to limbs and joints, Arthralgia alia sive NUD

3.6

38.3

126

349

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

38.3

3841

30873

R01AD12

ATC

fluticasone furoate; nasal

1.2

38.3

8279

72009

C02KX01

ATC

bosentan; oral

11.8

38.2

7169X

ICD-9 Finland

Other and unspecified arthropathies, Arthropathy, unspecified

6.2

38.1

105

ZX100

NOMESCO Finland

Oral

2.2

38.1

319

1444

KMAK, ,

NOMESCO Finland

1.2

38.0

13599

123271

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

37.9

6689

57090

7143A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[MB STILL]

83.6

37.7

EBA00

NOMESCO Finland

Extraction of tooth

1.2

37.6

9458

83310

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.4

37.5

1466

10225

SBA00

NOMESCO Finland

Microbiological examinations

1.8

37.4

615

3506

B01AF01

ATC

rivaroxaban; oral

1.3

37.3

2898

22544

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

37.2

1097

7234

9282

FHL

Ankle (TC) ossification surgery

10.5

37.2

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.7

37.2

695

4107

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

37.2

3137

24670

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

37.1

5495

46086

RF431, ,

NOMESCO Finland

12.8

37.1

B01AA03

ATC

warfarin; systemic

1.3

36.9

3961

32077

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

36.9

4797

39688

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.7

36.9

624

3587

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.2

36.9

317

1450

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

8.1

36.8

C08CA02

ATC

felodipine; oral

1.4

36.8

2078

15434

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.1

36.7

364

1760

7230B

ICD-9 Finland

Other disorders of cervical region, Spinal stenosis of cervical region[SUBLUXATIO ATLANTO-AXIALIS]

99.5

36.6

K11.7

ICD-10 Finland

Disturbances of salivary secretion

6.1

36.5

103

S01KA02

ATC

hypromellose; ophthalmic

2.0

36.4

412

2088

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

36.4

9355

82496

SPAT1254

SPAT

Administration of medicine

1.3

36.4

3469

27698

ZX108

NOMESCO Finland

Inhalation

2.7

36.4

190

692

L04AA14

ATC

[U] anakinra

+∞

36.4

D02AX

ATC

Other emollients and protectives

1.7

36.3

714

4277

N02AJ13

ATC

tramadol and paracetamol; systemic

1.8

36.0

551

3078

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

3.5

35.9

124

355

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

35.9

1097

7290

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.7

35.7

601

3450

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

35.7

6350

54193

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

35.7

7138

61577

M07.1*L40.5

ICD-10 Finland

Arthritis mutilans

79.7

35.7

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

35.6

7358

63662

WVA20, ,

SPAT

1.6

35.4

840

5273

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

3.4

35.4

126

368

WX200

NOMESCO Finland

Interscalenous plexus blockade

1.8

35.4

487

2634

JN6JR

NOMESCO Finland

Extensive PET-CT of whole body metabolism (crown to foot)

7.5

35.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

35.1

1797

13140

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

35.1

1739

12648

UJK02

NOMESCO Finland

ERCP

1.8

35.0

579

3308

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

35.0

1182

8016

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

2.6

35.0

198

752

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.6

34.9

725

4405

A02BA04

ATC

nizatidine; systemic

1.4

34.9

1641

11831

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.8

34.9

530

2955

NDB20

NOMESCO Finland

Primary total prosthetic replacement of joint of wrist not using cement, all parts

42.7

34.8

RF222, ,

NOMESCO Finland

12.0

34.7

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

34.7

1680

12170

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.2

34.6

298

1364

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.8

34.6

565

3216

M13

ICD-10 Finland

Other arthritis

5.2

34.6

133

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

34.5

1829

13446

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.1

34.5

319

1502

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

34.5

1077

7189

N04.2

ICD-10 Finland

Nephrotic syndrome, diffuse membranous glomerulonephritis

6.0

34.4

M54.2

ICD-10 Finland

Cervicalgia

1.4

34.4

1956

14540

X58

ICD-10 Finland

Exposure to other specified factors

1.3

34.4

3623

29261

7209X

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Unspecified inflammatory spondylopathy

51.0

34.3

TND11, ,

SPAT

5.5

34.2

120

K11.2

ICD-10 Finland

Sialoadenitis

1.6

34.2

793

4952

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

34.1

645

3825

ZZH30

NOMESCO Finland

Bone allograft

7.6

34.0

OAB93, ,

SPAT

1.4

33.9

1591

11462

NHG88

NOMESCO Finland

Fusion of several tarsal joints

6.2

33.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

33.8

3338

26756

M75.5

ICD-10 Finland

Bursitis of shoulder

1.7

33.7

565

3242

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

33.7

3498

28202

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.7

33.7

650

3876

A02BX02

ATC

sucralfate; oral

1.6

33.6

844

5370

D05AC01

ATC

dithranol; topical

6.7

33.6

L86

ICPC

Back syndrome with radiating pain

1.4

33.4

1498

10710

3AC01, ,

NOMESCO Finland

2.4

33.2

232

973

A60

ICPC

General and Unspecified, Result test/procedure

1.5

33.2

977

6440

M43.1

ICD-10 Finland

Spondylolisthesis

1.5

33.2

947

6201

127

Kela drug reimbursment

Transplant complication

2.0

33.2

353

1752

ND1DG

NOMESCO Finland

Wrist and hand very extensive MRI examination with high intensity magnet

4.2

33.0

210

G47.3

ICD-10 Finland

Sleep apnoea

1.2

33.0

5575

47306

S01ED01

ATC

timolol; ophthalmic

1.6

32.9

755

4703

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.6

32.9

688

4189

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

32.8

7097

61576

L40.1

ICD-10 Finland

Generalized pustular psoriasis

7.4

32.7

M70.2

ICD-10 Finland

Olecranon bursitis

1.6

32.7

699

4278

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

32.7

773

4850

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

1.8

32.7

471

2585

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

32.7

356

1782

NHC20

NOMESCO Finland

Secondary implantation of prosthesis in ankle joit

10.9

32.6

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

2.9

32.4

155

539

104

Kela drug reimbursment

Thyroid insufficiency

1.4

32.4

1684

12338

ZZH32

NOMESCO Finland

Bone allograft, block

7.7

32.4

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.5

32.4

931

6106

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.1

32.3

135

435

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

32.3

3355

27040

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

32.3

1022

6840

R80

ICD-10 Finland

Isolated proteinuria

2.5

32.2

198

783

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

2.2

32.1

258

1149

9508

FHL

Tendon or muscle transposition

9.4

32.1

R74

ICPC

Upper respiratory infection acute

1.2

31.9

8711

76998

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

31.8

4862

40839

SPAT1312

SPAT

General health counselling

1.2

31.8

7941

69696

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

2.1

31.7

291

1367

R13

ICD-10 Finland

Dysphagia

1.4

31.5

1588

11576

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

31.5

797

5082

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.3

31.5

2220

17030

NDR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of wrist or hand

2.1

31.4

300

1431

SPAT1104

SPAT

Monitoring of emergency patient

1.4

31.4

1416

10133

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

31.4

2259

17376

K07.24

ICD-10 Finland

Open bite

2.2

31.4

264

1199

3663A

ICD-9 Finland

Cataract secondary to ocular disorders

4.7

31.3

149

H19.3

ICD-10 Finland

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

5.4

31.3

112

RJ120, ,

NOMESCO Finland

5.4

31.3

112

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

2.0

31.3

330

1632

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

31.3

4597

38449

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

31.3

5069

42808

N08.5*M31.1

ICD-10 Finland

Glomerular disorders in thrombotic thrombocytopenic purpura

38.8

31.0

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.6

31.0

739

4646

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.6

31.0

727

4553

R81

ICPC

Pneumonia

1.5

31.0

859

5590

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

31.0

5445

46335

B02

ICD-10 Finland

Zoster [herpes zoster]

1.5

30.9

1016

6852

J01CF05

ATC

flucloxacillin; systemic

1.4

30.9

1601

11725

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.4

30.9

1319

9350

L45

ICPC

Musculoskeletal, Observ/health educat/advice/diet

4.5

30.8

163

K11.70

ICD-10 Finland

Hypoptyalism

2.6

30.8

173

655

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.2

30.8

262

1195

M073, L400,

ICD-10 Finland

305.4

30.7

B82

ICPC

Anaemia other/unspecified

1.6

30.7

647

3946

R01AD01

ATC

beclometasone; nasal

1.2

30.7

3630

29679

9251

FHL

Drainage or flushing of the joint under anesthesia

6.7

30.6

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

30.6

2352

18253

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

159.1

30.6

C03DA01

ATC

spironolactone; oral

1.3

30.6

2770

21956

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

30.6

3982

32896

EG1CM

NOMESCO Finland

Mandibular joint extensive MRI examination with 3 Tesla magnet

11.9

30.5

ND1DA

NOMESCO Finland

Bilateral wrist X-ray examination

11.9

30.5

9252

FHL

Plaster bandage placement or replacement (no fracture) in the operating room

5.8

30.5

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

1.6

30.5

642

3917

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

3.6

30.4

101

282

L02BG04

ATC

letrozole; oral

0.7

30.4

927

13517

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

30.3

902

5959

S76

ICPC

Skin infection other

1.4

30.3

1218

8540

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

30.2

5022

42498

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

3.0

30.2

131

432

M00.0

ICD-10 Finland

Staphylococcal arthritis and polyarthritis

4.3

30.1

174

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.7

30.1

532

3098

WVA30, ,

SPAT

1.4

30.0

1537

11232

RD210, ,

NOMESCO Finland

1.9

30.0

390

2073

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

7.6

29.9

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.1

29.9

268

1249

9321

FHL

The first reartroplast due to detachment, also includes the treatment of a fracture due to detachment

6.5

29.8

G63.6*M05.3

ICD-10 Finland

Rheumatoid polyneuropathy

300.8

29.7

M07

ICD-10 Finland

Psoriatic and enteropathic arthropathies

300.8

29.7

SCA02

NOMESCO Finland

Preventive oral health care

1.3

29.7

2401

18754

B01AX06

ATC

[U] rivaroxaban

1.8

29.7

465

2618

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

2.6

29.6

170

651

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

4.0

29.6

202

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

3.7

29.5

251

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.4

29.4

1285

9146

B99

ICD-10 Finland

Other and unspecified infectious diseases

1.8

29.4

415

2265

212

Kela drug reimbursment

Gout

1.9

29.3

365

1914

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

29.3

691

4335

EC1VA, ,

NOMESCO Finland

1.4

29.3

1123

7806

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

29.2

2706

21500

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

29.2

4855

41075

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.5

29.2

819

5345

SDA03

NOMESCO Finland

Periodontal treatment

1.2

29.1

10879

98286

C09CA01

ATC

losartan; oral

1.2

29.1

6205

53679

N05CF01

ATC

zopiclone; oral

1.2

29.1

8054

71168

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

2.6

29.0

167

640

D05AX

ATC

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5317

31296

1.83

310.67

3.2

4.6

241.31

242.43

u/l

0.23

5075

29690

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4731

26879

1.88

309.43

2.2

2.3

347.62

383.60

nmol/l

27.19

4445

24929

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

405

485

8.39

309.01

1.5

1.1

42.32

39.29

0.61

292

304

(3024263) Appearance of Synovial fluid

689

972

7.18

307.65

2.6

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1467

1775

8.56

307.65

1.8

1.2

36494.36

187181.49

e6/l

10.49

1017

1130

(3039162) Centromere protein B Ab [Units/volume] in Serum

1716

2997

5.96

307.65

1.5

1.2

57.35

54.78

u/ml

0.12

167

127

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1121

398

28.97

307.65

1.7

2.9

8.84

9.48

mg/l

1.52

879

358

(46235355) HIV 1 and 2 tests - Meaningful Use set

8603

50399

1.95

307.65

1.7

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

4537

9719

5.24

307.65

1.4

1.2

1.67

0.60

u/ml

4.28

382

770

(40758558) Short blood count panel - Blood

13589

83354

2.08

307.65

10.1

6.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

2538

5789

4.65

307.65

1.5

1.2

55.35

35.11

u/ml

6.75

410

412

(3018010) Neutrophils/Leukocytes in Blood

24296

128557

4.71

307.65

14.9

5.4

57.41

57.07

5.24

23945

122417

(3008898) HLA-B27 [Presence]

4005

8454

5.24

307.65

1.1

—

(3017732) Neutrophils [#/volume] in Blood

9348

32949

3.57

307.65

3.9

3.0

4.17

4.60

e9/l

4.93

8444

28297

(3021589) Normoblasts [#/volume] in Blood

19723

122372

2.58

307.65

20.2

10.5

0.00

e9/l

3.84

17632

98549

(3023368) Bacteria identified in Blood by Culture

10736

74387

1.65

307.65

4.9

4.3

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

446

492

9.12

307.65

1.7

1.2

46.10

59.77

8.14

404

399

(3015736) pH of Urine

19481

117719

2.66

307.65

5.2

3.3

6.29

6.22

12.57

10140

65894

(36304419) Bacteria [Presence] in Urine

11079

74029

1.75

307.65

4.0

3.2

286.69

129.66

estimate

0.24

316

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

852

1985

4.35

307.65

1.5

1.2

241.11

128.00

titre

1.05

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

4280

5104

9.47

307.65

1.8

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

29822

270057

2.54

307.65

29.0

15.0

17.93

24.10

mg/l

308.27

27800

220204

(3029075) Extractable nuclear Ab panel - Serum

795

1508

5.35

307.65

1.1

0.19

0.28

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

11899

67105

2.22

307.65

6.0

3.6

0.43

0.28

0.51

669

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1513

3905

3.99

307.65

2.2

1.2

12.49

15.28

u/ml

0.43

(3034891) Synovial lining cells/cells in Synovial fluid

986

795

12.68

307.65

1.7

1.3

4.62

3.32

1.04

260

141

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1550

4560

3.50

307.65

1.6

1.2

422.65

188.03

titre

4.34

202

277

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1706

3492

5.07

307.65

1.3

1.1

26.36

9.24

u/ml

3.33

125

110

(3045424) Erythrocytes [Presence] in Urine

3708

12650

3.16

307.65

2.5

2.1

0.02

0.17

estimate

0.98

1416

3822

(3003329) Lymphocytes/Leukocytes in Synovial fluid

1719

1562

11.50

307.65

1.9

1.3

39.05

25.99

23.43

1131

889

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3126

9107

3.67

307.65

1.7

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

16943

125859

1.72

307.65

6.5

4.9

35.42

35.87

g/l

22.62

16135

117794

(3002582) Erythrocytes [#/volume] in Urine

13051

90008

1.75

307.65

4.5

3.3

49.96

82.57

e6/l

3.54

10736

67686

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7445

44699

1.85

307.65

2.7

2.6

2.30

2.36

g/l

12.43

6984

41171

(3023420) DNA double strand Ab [Units/volume] in Serum

6304

9391

8.07

307.65

2.7

1.5

10.28

5.91

iu/ml

6.27

1852

1939

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17467

125478

1.85

307.65

7.2

6.6

1.22

1.21

mmol/l

8.05

16664

115990

(3041096) Erythrocytes [Presence] in Urine by Automated

11857

79703

1.76

307.65

4.9

3.2

0.11

0.29

estimate

1.50

5114

23284

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3681

7731

5.22

307.65

3.0

1.3

1.16

1.20

g/l

12.84

3566

7379

(3037522) Nuclear Ab [Titer] in Serum

13558

36147

5.75

307.65

1.7

1.3

706.96

449.20

titre

37.70

4113

6805

(3036071) Salmonella sp Ab [Titer] in Serum

537

610

8.88

307.65

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

12357

80295

1.86

307.65

4.1

2.8

0.07

0.06

151

1866

(3022096) Basophils/Leukocytes in Blood

24243

127554

4.73

307.65

15.6

5.5

0.75

0.68

97.07

23769

118968

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

352

218

16.21

307.65

1.7

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

23323

145864

3.20

307.65

6.0

3.7

0.00

estimate

1.31

5823

29391

(3034770) Mitochondria Ab [Titer] in Serum

2330

7469

3.26

307.65

1.6

1.2

1069.39

738.20

titre

2.06

213

100

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

435

95.23

307.65

1.6

2.6

1.56

2.60

mg/l

5.01

368

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3646

7464

5.35

307.65

3.0

1.4

0.21

0.24

g/l

54.44

3516

7100

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

611

719

8.59

307.65

2.9

3.9

7.27

8.90

mg/l

4.71

455

595

(3007164) IgA [Mass/volume] in Serum or Plasma

9453

57563

1.90

307.65

1.7

1.5

2.55

2.34

g/l

20.89

6692

34967

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

979

2189

4.55

307.65

1.4

1.2

78.22

66.18

u/ml

0.51

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

6183

5925

12.63

307.65

1.6

1.5

3.09

7.91

iu/ml

0.57

1162

1046

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7045

40954

1.91

307.65

2.7

2.6

21.99

22.57

2.96

6637

37955

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

852

1990

4.34

307.65

1.5

1.2

260.24

148.35

titre

3.44

249

248

(3001604) Monocytes [#/volume] in Blood

26773

138526

6.80

307.65

14.9

5.3

0.58

e9/l

5.64

25206

117834

(3002030) Lymphocytes/Leukocytes in Blood

24452

131178

4.68

307.65

15.2

5.5

28.23

28.07

1.76

24051

123966

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

3307

7128

5.03

307.65

1.5

1.2

12.64

5.31

u/ml

6.98

801

803

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1446

2215

6.75

307.65

1.3

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

14323

98741

1.80

307.65

5.1

3.3

2.51

1.85

e6/l

—

(3004616) Nuclear Ab [Presence] in Serum

1299

3222

4.13

307.65

1.4

1.3

—

(3006315) Basophils [#/volume] in Blood

26802

138922

6.81

307.65

15.0

5.3

0.04

e9/l

10.20

25230

118131

(3027945) Reticulocytes/Erythrocytes in Blood

5422

30799

1.90

307.65

2.9

2.6

1.81

1.78

1.94

4963

27363

(3013115) Eosinophils [#/volume] in Blood

26963

143475

6.68

307.65

15.2

5.5

0.18

0.19

e9/l

32.26

25611

124149

(3035350) Ketones [Presence] in Urine by Test strip

23441

147681

3.19

307.65

6.1

3.7

4.71

3.71

estimate

0.42

5937

30130

(3024980) IgG subclass 4 [Mass/volume] in Serum

1635

4327

3.90

307.65

2.0

1.5

0.73

0.76

g/l

0.41

1305

3374

(3017143) Hepatitis C virus Ab [Presence] in Serum

7902

30676

3.07

307.65

1.4

1.7

—

(3006504) Eosinophils/Leukocytes in Blood

24331

127485

4.81

307.65

15.3

5.5

2.73

2.85

17.74

23858

119028

(3018095) Leukocytes [#/volume] in Urine

15819

103036

2.04

307.65

5.5

3.9

79.18

99.34

e6/l

2.25

11117

71667

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19217

140352

1.91

307.65

8.1

7.1

1.22

1.21

mmol/l

4.00

16957

121071

(3000475) Leukocytes [#/volume] in Synovial fluid

3832

4995

8.53

307.65

2.1

1.4

9096.74

15542.74

e6/l

11.33

2945

3375

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11952

85490

1.62

307.65

2.7

2.2

150.14

204.07

u/l

14.25

11430

80732

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1245

1840

6.95

307.65

1.3

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

19791

128499

2.40

307.65

3.2

2.4

78.02

781.11

nmol/l

0.50

18845

116524

(3026493) Urate [Moles/volume] in Serum or Plasma

12774

70700

2.33

307.65

2.8

2.6

322.95

337.96

umol/l

56.97

11658

62315

(3042936) Bacteria identified in Isolate by Culture

6995

38345

2.04

307.65

2.4

2.0

—

(3019069) Monocytes/Leukocytes in Blood

24397

127817

4.84

307.65

15.5

5.5

9.03

8.72

61.59

23915

119426

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

28774

203784

5.21

307.65

12.6

3.6

13.69

11.77

mm/h

101.26

28244

190337

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1555

4603

3.48

307.65

1.6

1.2

156.76

110.36

titre

0.53

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2254

7218

3.26

307.65

2.4

1.3

13.18

15.47

iu/ml

0.39

121

120

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11084

73073

1.78

307.65

2.8

2.3

2.97

2.79

mg/l

14.05

9990

63021

(3002179) Metamyelocytes/Leukocytes in Blood

7120

21537

3.94

307.65

6.2

3.8

0.44

0.77

28.20

1875

6541

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

28412

210740

4.17

307.65

14.7

7.7

76.55

79.23

u/l

24.28

28023

199693

(3018418) pH of Serum or Plasma

13091

83795

1.94

307.65

4.5

4.3

7.40

0.65

9704

59462

(3007566) Smooth muscle Ab [Titer] in Serum

2315

7608

3.18

307.65

1.6

1.2

189.82

107.60

titre

2.06

221

725

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2658

11522

2.41

307.65

1.7

2.1

37.92

40.10

u/l

6.77

2428

10282

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1040

1003

10.62

307.65

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1235

2554

4.96

307.65

1.3

1.2

51.92

38.30

u/ml

0.97

117

(3029937) Albumin [Presence] in Urine by Test strip

13702

79960

2.23

307.65

6.6

3.9

0.00

estimate

6.72

5662

27150

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

3416

7745

4.79

307.65

1.5

1.2

48.90

30.05

u/ml

3.24

340

307

(3018333) Ribosomal P Ab [Presence] in Serum

1216

1777

7.03

307.65

1.3

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

26867

141911

6.66

307.65

15.1

5.3

1.85

1.93

e9/l

18.94

25567

123823

(3045414) Leukocytes [Presence] in Urine

5798

25947

2.49

307.65

2.4

2.0

0.00

0.03

estimate

6.71

1545

4955

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2606

8457

3.25

307.65

1.3

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

10042

61124

1.92

307.65

3.5

2.7

4.64

6.13

e6/l

24.30

9370

55387

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

715

1206

6.00

307.65

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2060

6402

3.35

307.65

1.2

1.3

—

(3025159) Blasts/Leukocytes in Blood

7082

22012

3.82

307.65

7.3

4.1

0.18

0.33

1.08

1676

5659

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

558

639

8.81

307.65

2.5

2.9

171.99

124.76

au/ml

1.06

(3020630) Protein [Mass/volume] in Serum or Plasma

4606

22002

2.26

307.65

2.0

2.8

66.67

66.32

g/l

2.17

4323

20061

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1292

1993

6.67

307.65

1.3

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

3304

7148

5.01

307.65

1.5

1.2

8.60

3.49

u/ml

2.99

564

481

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2976

6139

5.21

307.65

1.4

1.2

18.32

13.26

u/ml

0.35

(3028026) IgM [Mass/volume] in Serum or Plasma

5140

15373

3.77

307.65

2.0

1.9

1.34

1.29

g/l

0.91

4858

14067

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

13522

46264

4.31

307.65

1.5

1.3

43.64

2.94

u/ml

204.42

5910

17689

(3038026) Centromere Ab [Units/volume] in Serum

922

1819

5.16

307.65

1.4

1.2

69.14

43.24

u/ml

1.65

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8989

42381

2.54

307.65

1.5

1.7

—

(3021788) Differential panel - Synovial fluid

3182

3649

9.51

307.65

1.9

1.4

1.00

—

(3009261) Glucose [Presence] in Urine by Test strip

23481

148894

3.16

307.65

6.1

3.8

0.01

0.29

estimate

2.58

5703

28616

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1279

1943

6.77

307.65

1.3

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

7325

22738

3.86

307.65

6.8

3.9

0.70

0.99

15.31

1971

6856

(3030467) Casts [#/volume] in Urine by Automated count

11552

77827

1.75

307.65

4.2

3.2

0.31

0.42

e6/l

8.48

9233

56077

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1231

1836

6.89

307.65

1.3

1.1

—

(3019150) Specific gravity of Urine by Refractometry

9803

65265

1.71

307.65

6.8

3.8

1.16

kg/l

0.01

7311

42462

(3022948) Iron [Moles/volume] in Serum or Plasma

8012

47956

1.88

307.65

2.8

2.6

12.42

13.23

umol/l

19.91

7564

44619

(3006571) Granulocytes/Leukocytes in Synovial fluid

2259

2125

11.29

307.65

1.9

1.3

50.21

60.94

17.54

1532

1249

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2102

1909

11.64

307.65

1.1

1.60

2.42

iu/ml

0.97

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

367

111.76

307.65

1.5

2.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

893

277

32.92

307.65

1.5

2.2

148.43

90.50

au/ml

1.63

129

(3021440) Promyelocytes/Leukocytes in Blood

7049

21744

3.85

307.65

6.9

3.9

0.07

0.13

9.48

1688

5899

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3646

10608

3.73

307.65

2.7

1.3

16.80

11.42

iu/ml

1.65

288

148

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

16538

111119

2.00

307.65

6.1

3.7

0.13

0.67

estimate

3.52

5139

23824

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13510

50780

3.86

307.65

1.5

1.3

72.57

22.21

iu/ml

68.43

5971

14128

(3013650) Neutrophils [#/volume] in Blood by Automated count

27277

156478

6.12

307.65

17.8

8.8

3.96

4.11

e9/l

27.01

25785

134346

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1262

1918

6.77

307.65

1.3

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

6749

19570

4.08

307.65

4.1

2.6

10.74

10.50

g/l

4.11

6460

17950

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1261

1915

6.77

307.65

1.3

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2918

5900

5.31

307.65

1.5

1.2

6.69

4.31

u/ml

0.73

316

304

(3037467) Urinalysis macro (dipstick) panel - Urine

26378

188132

3.30

307.65

8.3

4.3

2.41

48.05

0.52

302

(3023520) Reticulocytes [#/volume] in Blood

4279

23608

1.93

305.92

2.6

69.94

69.80

e9/l

0.09

3112

17290

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1825

7238

2.60

295.16

1.7

2.2

11.14

11.46

mg/l

0.85

1712

6778

(3048689) Calprotectin [Mass/mass] in Stool

6106

38004

1.74

292.80

2.9

2.4

152.79

126.78

ug/g

7.16

5116

29993

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4016

21996

1.93

292.50

2.8

2.4

0.25

0.43

e6/l

11.54

3765

21016

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

663

1382

4.85

292.28

2.2

1.2

5.82

5.71

u/l

0.15

591

1169

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7411

48972

1.66

282.69

3.5

2.9

0.92

1.22

e6/l

3.11

4646

25299

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1501

5522

2.78

281.38

5.2

5.9

620.61

1179.71

iu/ml

0.94

182

835

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

18207

147865

1.52

275.96

7.5

6.5

10.31

11.31

umol/l

28.29

17504

140678

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

728

1716

4.29

275.18

1.7

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2346

10758

2.26

274.33

1.8

2.4

3.80

3.68

g/l

3.64

2195

9759

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2348

10796

2.25

272.75

1.8

2.4

7.67

7.33

g/l

16.70

2197

9784

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2345

10782

2.25

272.40

1.8

2.4

4.25

4.23

g/l

0.52

2194

9785

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3615

19652

1.93

267.67

2.4

22.18

21.32

au/ml

0.25

351

2208

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

399

556

7.21

267.33

1.9

1.6

8.91

9.54

ug/l

1.64

399

556

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2232

10204

2.26

262.56

1.8

2.4

3.10

2.86

g/l

22.38

2081

9193

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3372

18119

1.95

257.87

1.3

49.85

51.86

au/ml

0.21

168

1162

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2508

12102

2.15

257.82

1.8

1.7

1.56

1.53

g/l

0.77

2160

10374

(3028192) IgG subclass 2 [Mass/volume] in Serum

923

2764

3.39

247.06

1.5

1.4

2.80

2.94

g/l

1.47

672

2007

(3027135) IgG subclass 1 [Mass/volume] in Serum

923

2766

3.38

246.77

1.5

1.4

7.03

6.70

g/l

1.40

674

2009

(3024139) IgG subclass 3 [Mass/volume] in Serum

922

2764

3.38

246.36

1.5

1.4

0.44

0.40

g/l

0.89

673

2007

(3032080) INR in Blood by Coagulation assay

15757

125905

1.48

245.74

14.6

14.1

1.21

1.24

inr

7.78

13321

104760

(4062490) Immunoglobulin typing, IgG

910

2712

3.40

245.43

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2045

9280

2.27

244.36

1.7

2.4

10.69

10.00

g/l

8.81

1882

8169

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

234

+∞

243.42

1.3

0.0

1.67

—

mg/l

—

199

(40768441) Liver Pathology biopsy report

717

1831

3.96

243.14

1.7

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1812

7834

2.38

242.28

1.8

2.4

0.01

0.03

g/l

3.47

1660

7014

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2041

9287

2.26

242.24

1.8

2.6

0.54

0.81

g/l

3.57

1810

7929

(42529582) MDA5 Ab [Presence] in Serum by Line blot

387

591

6.57

238.08

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

387

591

6.57

238.08

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

387

591

6.57

238.08

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

387

591

6.57

238.08

1.2

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

21480

183313

1.50

236.24

5.8

4.7

1557.01

1931.58

e6/l

0.35

266

2496

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6746

45458

1.60

230.47

2.1

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1709

7379

2.37

228.90

1.8

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1921

8750

2.26

227.04

2.8

2.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1721

7533

2.34

223.31

1.8

2.4

0.00

g/l

2.31

1532

6563

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

25499

226870

1.59

222.08

32.8

18.4

13.96

13.57

307.65

25391

223858

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1917

8840

2.23

219.70

2.1

3.6

39.19

42.73

mg/l

0.34

1560

7574

(3034860) Kappa light chains.free [Mass/volume] in Serum

1916

8861

2.22

217.99

2.1

3.6

46.85

66.36

mg/l

1.45

1560

7591

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1619

7033

2.36

213.57

1.8

2.5

0.00

g/l

-0.00

1530

6546

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10635

80216

1.48

212.18

3.4

3.1

1254.04

1303.44

ng/l

0.59

9355

68515

(3001122) Ferritin [Mass/volume] in Serum or Plasma

16661

136924

1.44

209.82

3.7

3.2

130.20

117.42

ug/l

7.24

15783

128123

(3009871) Measles virus Ab [Titer] in Serum

454

919

4.96

207.09

1.6

3911.82

3489.15

titre

0.43

142

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1250

4892

2.60

206.48

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1419

5917

2.45

204.97

1.6

1.4

—

(40761536) Microorganisms panel - Urine sediment

3670

21776

1.76

201.25

5.3

3.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

12557

98473

1.44

201.09

3.1

3.6

2.35

2.36

mmol/l

15.74

11674

89567

(3026782) Osmolality of Urine

7439

52678

1.53

199.47

3.7

2.9

517.52

526.64

mosm/kgh2o

3.21

6718

46001

(3000494) Fungus identified in Specimen by Culture

5185

33849

1.62

198.19

1.7

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

5070

32927

1.63

197.88

2.0

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1509

6574

2.34

197.46

1.7

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4304

26867

1.68

195.94

3.3

2.2

0.21

g/l

0.98

4070

25046

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1705

7858

2.22

195.12

2.0

3.5

2.51

6.14

ratio

1.59

956

4581

(3021960) Folate [Moles/volume] in Serum or Plasma

10430

79329

1.46

195.07

1.8

1.7

20.70

20.34

nmol/l

1.13

9051

67575

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2061

10243

2.07

194.17

2.1

1.9

1.82

2.35

ug/l

0.99

1855

9037

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1128

4336

2.64

193.09

2.8

3.0

1572.54

5860.13

u/ml

0.96

246

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1532

6796

2.30

192.12

1.7

1.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

28166

259127

1.70

188.25

23.6

14.8

84.43

81.75

ml/min/173m2

89.45

26943

238588

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1288

5358

2.45

186.77

1.8

1.6

—

(3004809) Band form neutrophils/Leukocytes in Blood

1092

4199

2.64

186.74

3.0

3.5

1.20

1.59

3.01

1002

3737

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5103

33628

1.60

186.43

2.0

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4809

31569

1.60

177.66

2.1

1.8

—

(3037756) Immunofixation for Serum or Plasma

1255

5277

2.42

177.62

1.3

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12029

95084

1.41

177.25

4.7

3.2

34.34

33.06

u/l

1.10

11430

89768

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1008

3829

2.67

176.54

1.6

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

348

657

5.31

171.91

1.4

1.2

39.39

40.24

g/l

0.42

202

318

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9002

68066

1.44

167.73

1.4

1.3

1.18

1.64

u/ml

5.25

2498

18506

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

814

2863

2.87

165.13

1.2

54.18

63.86

u/l

3.90

739

2490

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3352

20503

1.70

162.50

1.8

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1169

4994

2.38

159.47

1.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1068

4406

2.46

157.40

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3463

21605

1.66

155.30

3.8

3.9

1.23

mmol/l

1.55

3134

18497

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

910

3541

2.60

151.66

3.7

2.7

113.73

587.06

u/ml

1.02

904

3503

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

736

2569

2.89

151.36

2.0

1.2

87.09

43.39

u/ml

0.38

(3007916) DNA double strand Ab [Titer] in Serum

197

239

8.23

148.74

1.6

1.1

176.90

59.10

titre

—

(3011412) CD3 cells [#/volume] in Blood

707

2457

2.90

146.55

2.0

2.5

1076.24

1245.87

e6/l

2.71

631

2140

(3035947) Staphylolysin Ab [Units/volume] in Serum

437

1163

3.77

139.67

1.1

3.13

3.87

iu/ml

1.01

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

817

3174

2.60

136.54

1.6

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

994

4272

2.35

133.54

1.4

1.2

4.43

3.58

u/ml

0.64

480

1541

(3016650) Hepatitis A virus Ab [Presence] in Serum

1038

4589

2.29

130.56

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

257

474

5.42

130.34

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1174

5485

2.17

128.99

1.6

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8191

63256

1.39

127.77

1.9

1.8

1.32

1.19

mg/l

2.94

6539

48945

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

959

4178

2.32

124.80

1.3

1.2

4.20

3.86

u/ml

0.37

481

1934

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1199

5725

2.12

124.53

1.3

28.01

51.65

u/ml

2.58

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1143

5360

2.16

124.36

1.3

292.08

262.80

u/ml

2.20

683

3430

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1234

5972

2.10

123.70

1.5

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5171

37003

1.46

123.13

6.7

5.9

1.04

mmol/l

0.26

4903

34317

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

807

3275

2.49

123.04

1.7

1.5

—

(3010503) CD19 cells [#/volume] in Blood

474

1459

3.26

121.17

2.0

2.7

147.83

339.17

e6/l

1.61

457

1418

(3013826) Glucose [Moles/volume] in Serum or Plasma

18621

163477

1.32

117.95

5.8

5.0

6.54

6.67

mmol/l

15.33

17849

154653

(3022145) Colonoscopy Study observation

4639

32814

1.47

116.57

1.6

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

6161

46000

1.41

115.36

1.8

1.7

1184.24

1165.35

nmol/l

0.89

4955

34798

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1738

9683

1.83

115.08

2.4

2.2

359.11

575.24

ug/l

1.85

1592

9158

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11096

91086

1.32

112.41

2.9

2.7

62.50

69.20

u/l

0.46

10380

84380

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7295

56243

1.37

112.22

2.7

3.0

2.46

2.45

mmol/l

6.19

6596

50335

(3048929) Epstein Barr virus Ab [Presence] in Serum

1618

8885

1.85

112.19

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1150

5634

2.07

111.43

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

29896

284747

1.71

110.33

27.7

11.1

26.34

25.93

u/l

3.29

29663

276726

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1134

5588

2.05

108.13

1.4

30.56

21.00

u/ml

1.04

104

(3017354) Segmented neutrophils/Leukocytes in Blood

689

2762

2.51

107.80

2.9

3.5

56.78

57.36

0.31

597

2354

(3037692) Legionella sp identified in Specimen by Organism specific culture

309

779

3.97

106.69

1.3

1.4

—

(3001729) Color of Synovial fluid

121

120

10.05

106.64

2.3

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

386

1136

3.40

106.07

1.2

1.1

27.00

7.09

u/ml

1.16

119

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

172

263

6.53

105.80

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

486

1651

2.95

104.97

1.3

1.2

97.40

90.42

u/l

0.56

435

1400

(4268621) Lupus anticoagulant assay

717

2969

2.43

104.59

2.4

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3550

24277

1.51

104.46

8.6

7.4

9.66

9.68

mmol/l

0.06

3419

23208

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

477

1615

2.96

103.65

1.3

1.2

23.06

24.61

u/l

0.24

423

1339

(3010375) cycloSPORINE [Mass/volume] in Blood

363

1043

3.49

103.55

27.6

31.5

117.37

117.18

ug/l

0.01

315

863

(1175426) CD3 cells/Lymphocytes in Blood

549

2014

2.74

102.78

2.0

2.2

74.00

72.52

1.45

518

1942

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3280

22135

1.53

102.65

3.1

2.7

66.76

66.99

ml/min/173m2

0.12

1460

9274

(44790047) Parainfluenza type 1 nucleic acid detection

774

3348

2.33

102.31

1.7

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1048

5122

2.07

102.12

1.5

151.15

149.24

au/ml

0.17

249

1505

(44806118) Parainfluenza type 4 nucleic acid detection

773

3345

2.33

102.09

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

773

3345

2.33

102.09

1.7

1.5

—

(40768443) Skin Pathology biopsy report

2117

12894

1.68

102.06

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

773

3346

2.33

102.02

1.7

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30006

286661

1.70

101.69

33.2

19.5

74.86

75.65

umol/l

3.92

29864

283336

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3237

21909

1.52

99.74

4.3

3.9

80.57

88.63

ng/l

4.89

2875

18927

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

464

1581

2.94

99.69

1.6

1.5

6.01

6.87

u/l

0.67

370

1248

(40768797) Stomach Pathology biopsy report

5301

39639

1.39

96.07

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

521

1932

2.71

95.53

1.9

2.1

15.36

14.83

0.47

503

1883

(21494815) CD4 cells/Lymphocytes in Specimen

574

2238

2.58

95.17

1.9

2.3

43.96

38.51

13.30

560

2203

(3042631) Mycobacterium sp identified in Specimen

751

3309

2.29

95.07

2.8

2.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

448

1540

2.92

94.75

1.2

1.1

1.08

1.06

ratio

1.49

386

1262

(3033099) Centromere Ab [Titer] in Serum

263

649

4.05

93.57

1.1

—

(3044927) Protein electrophoresis panel - Urine

588

2371

2.49

90.86

1.2

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

101

100

10.06

89.13

2.6

1.1

0.45

0.88

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

943

4675

2.03

88.30

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5877

45322

1.35

86.74

4.0

3.0

2.62

3.31

e6/l

5.00

3098

21562

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

484

1820

2.67

86.36

2.1

2.8

200.84

237.47

e6/l

2.71

419

1527

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

817

3889

2.12

85.32

1.1

1.53

1.50

g/l

1.68

761

3548

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

360

1163

3.10

84.97

1.2

1.1

197.05

208.15

iu/ml

0.20

355

1155

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12239

104422

1.27

84.39

4.2

3.7

136.11

50.02

ng/l

1.18

8615

69951

(3014148) Varicella zoster virus Ab [Titer] in Serum

788

3721

2.13

84.02

1.1

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

304

893

3.40

83.87

1.6

1.9

36671.34

21858.42

u/ml

0.23

129

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

469

1763

2.67

83.75

2.0

2.7

442.14

544.02

e6/l

2.79

377

1404

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

14299

124393

1.26

83.06

2.3

2.1

95.30

97.20

pmol/l

5.14

8167

64956

(37208534) Antinuclear antibody arbitrary concentration in serum

306

911

3.36

82.66

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

587

2474

2.38

82.33

2.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

721

3322

2.18

81.84

2.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

537

2182

2.47

81.64

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

10.07

81.25

1.4

1.1

20.20

12.87

u/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

813

3941

2.08

80.90

1.1

0.51

5.92

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

423

1537

2.76

80.72

1.6

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15023

131779

1.25

79.90

3.0

2.8

—

estimate

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1427

8421

1.72

76.89

4.9

3.7

1.53

1.51

mg/l

0.47

1317

7697

(21491868) Cryoglobulin [Mass/volume] in Serum

302

935

3.23

76.60

1.2

0.45

g/l

0.00

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

386

1375

2.81

76.51

1.6

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7170

57757

1.30

76.44

1.7

25806898.52

33874555.74

pmol/l

0.55

6107

48140

(3037121) Protein [Mass/volume] in Urine

1527

9209

1.68

75.88

4.0

3.3

359.72

544.42

mg/l

2.50

742

4077

(3033658) Prothrombin time (PT) actual/Normal

8716

72052

1.28

75.79

5.8

4.0

91.61

90.89

2.00

8498

70434

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4257

31854

1.38

74.86

8.4

7.6

5.07

5.10

kpa

1.32

4104

30688

(3016502) Oxygen saturation in Arterial blood

3835

28220

1.40

74.58

8.7

8.0

95.45

95.66

1.20

3714

27268

(3027801) Oxygen [Partial pressure] in Arterial blood

4253

31841

1.38

74.51

8.3

7.6

12.32

12.59

kpa

2.72

4096

30656

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

394

1443

2.73

74.09

1.6

1.4

—

(3019977) pH of Arterial blood

4248

31880

1.37

73.21

8.4

7.7

7.42

2.65

2376

17200

(3016228) CD19 cells/cells in Blood

300

952

3.15

73.06

1.9

2.1

7.41

8.50

0.89

288

930

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5408

42135

1.33

72.83

2.3

2.1

29.57

29.53

0.16

5248

40981

(3003396) Base excess in Arterial blood by calculation

4212

31640

1.37

72.05

8.3

7.6

1.03

0.95

mmol/l

0.66

3541

26224

(40768446) Kidney Pathology biopsy report

310

1018

3.05

71.21

1.4

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

600

2718

2.22

71.05

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

257

756

3.40

70.82

1.8

2.0

2.13

1.69

ratio

3.23

244

729

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4402

33401

1.36

70.50

4.0

2.7

7.88

8.34

umol/l

0.69

3847

29033

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

264

794

3.32

70.24

1.2

1.1

2.86

4.86

u/ml

0.68

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

469

1922

2.45

70.04

1.6

1.4

12.01

12.50

umol/l

0.85

457

1811

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

294

947

3.10

69.83

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

469

1933

2.43

69.18

1.6

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

399

1525

2.62

68.99

1.2

1.1

22.49

23.89

u/l

0.24

365

1347

(3019550) Sodium [Moles/volume] in Serum or Plasma

28727

274470

1.41

68.08

23.1

18.2

139.44

139.70

mmol/l

60.91

28314

269171

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

199

508

3.91

67.69

1.2

1.1

39.07

17.67

u/ml

0.93

(3005322) IgE [Units/volume] in Serum or Plasma

2750

19390

1.45

67.55

1.4

1.3

145.87

237.20

u/ml

9.70

2563

18078

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

398

1536

2.59

67.49

1.2

1.1

85.23

82.85

u/l

0.27

365

1354

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5965

47551

1.30

67.44

3.7

3.5

0.81

0.82

mmol/l

7.70

5639

44669

(3023103) Potassium [Moles/volume] in Serum or Plasma

28765

274981

1.41

67.15

23.4

18.4

3.94

3.96

mmol/l

25.45

28312

269253

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

557

2506

2.23

67.09

1.8

1.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

490

2102

2.34

66.08

1.9

1.8

3.30

3.85

mg/l

2.50

471

2018

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

381

1455

2.62

66.01

2.4

2.9

43.90

38.69

6.02

230

802

(3039744) RNA polymerase III Ab [Units/volume] in Serum

113

183

6.15

65.83

1.0

1.1

7.19

3.78

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3653

27190

1.38

65.66

3.6

3.4

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

+∞

65.47

1.2

0.0

341.00

—

au/ml

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

418

1740

2.41

60.37

2.0

2.7

0.68

0.71

e9/l

0.34

389

1670

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

665

3334

2.00

60.33

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3526

26461

1.36

59.79

9.3

8.4

118.53

121.05

g/l

11.55

3453

25877

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3692

27951

1.35

59.11

4.7

4.0

5.83

5.82

kpa

0.04

3599

27289

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

669

3388

1.98

58.99

2.2

32.25

32.41

0.40

659

3368

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1337

8313

1.62

58.71

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1257

7702

1.65

58.53

2.9

3.2

2.39

2.18

index

0.21

601

3930

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1328

8263

1.62

58.14

1.4

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

210

633

3.31

55.78

1.1

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2126

14835

1.45

54.73

1.1

7.22

8.65

u/ml

0.08

156

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

472

2164

2.18

54.34

1.1

293.75

427.38

mg/l

0.49

438

1958

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2522

18183

1.41

54.21

4.6

3.7

5.12

5.15

kpa

1.17

2440

17300

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

343

1375

2.49

53.83

1.2

—

(3010421) pH of Blood

1349

8588

1.59

53.64

3.8

3.5

7.41

0.54

1333

8463

(3012544) pH of Venous blood

3688

28335

1.33

53.05

4.8

4.0

7.38

0.38

2098

16193

(3000012) Reticulocyte production index

688

3649

1.89

52.91

2.3

2.2

0.92

0.90

0.33

497

2425

(3025941) Bacteria identified in Stool by Culture

2218

15696

1.43

52.88

1.3

1.2

—

(3009343) pH of Capillary blood

2451

17668

1.41

52.68

4.6

3.7

7.42

1.67

2085

14643

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2822

20838

1.38

52.55

3.1

2.9

186.58

191.92

ng/l

0.26

2577

19065

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1088

6632

1.65

51.66

2.6

2.2

127.12

129.84

g/l

2.93

764

5129

(3002032) Base excess in Venous blood by calculation

3548

27233

1.33

51.25

4.8

4.0

1.81

mmol/l

0.03

3157

23996

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

341

1397

2.44

51.09

1.3

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2005

14032

1.45

50.70

1.1

138.10

198.77

titre

0.57

377

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

468

2203

2.13

50.41

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

463

2180

2.13

49.84

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

463

2180

2.13

49.84

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

463

2180

2.13

49.84

1.6

—

(36660697) Celiac disease serology panel - Serum

3167

24004

1.35

49.74

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2311

16649

1.41

49.73

7.1

6.8

24.70

24.56

mmol/l

1.08

2215

15965

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2305

16607

1.41

49.57

1.8

1.7

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

381

1663

2.29

49.46

2.2

2.7

1042.71

1020.45

u/ml

0.06

373

1645

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

213

699

3.04

49.15

1.9

3.4

2.24

1.81

ratio

2.54

197

636

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

428

1965

2.18

49.15

1.3

1.2

77.79

80.68

0.27

129

(3022621) pH of Urine by Test strip

3014

22751

1.35

48.58

3.3

2.5

6.05

6.08

1.16

2011

14986

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

941

5615

1.69

48.49

2.9

3.3

8.05

9.11

pmol/l

2.34

941

5610

(21494890) Protein electrophoresis panel - 24 hour Urine

519

2583

2.01

48.14

1.6

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2376

31686

0.72

47.66

1.8

1.9

3.41

3.45

ratio

0.66

1818

24165

(3000093) Morphology [Interpretation] in Blood Narrative

506

2511

2.02

47.32

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

296

1187

2.49

46.49

42.0

40.6

6.82

7.27

ug/l

3.93

279

1061

(3020891) Body temperature

1813

12680

1.45

45.89

4.5

4.6

36.90

36.91

°c

0.26

1792

12565

(3017704) Immunofixation for Urine

320

1342

2.38

45.59

1.3

1.8

—

(3021901) Oxygen saturation in Capillary blood

923

5585

1.66

45.10

3.4

3.0

89.72

90.32

1.74

903

5423

(3044889) 12 lead EKG panel

20540

191154

1.19

45.09

4.4

4.0

0.27

3109.75

1.35

383

(3028433) Virus identified in Specimen by Culture

218

764

2.85

44.77

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1417

9499

1.50

44.47

3.4

2.9

24.68

24.76

mmol/l

0.33

1393

9320

(3000991) Gas panel - Venous blood

3172

24440

1.32

44.19

10.3

8.9

—

(3013727) Leukocytes other/Leukocytes in Blood

209

724

2.88

43.86

3.6

3.5

50.35

53.56

1.21

204

699

(3014111) Lactate [Moles/volume] in Serum or Plasma

3259

25240

1.32

43.73

8.7

7.6

1.33

mmol/l

0.08

3205

24766

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2129

15467

1.39

43.43

4.5

3.6

1.93

1.75

mmol/l

1.46

1591

11364

(3028626) Oxygen [Partial pressure] in Capillary blood

1100

7032

1.57

42.90

4.4

3.5

8.31

8.36

kpa

0.35

1084

6848

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

328

1441

2.27

42.02

1.1

1457.70

1530.55

miu/ml

0.61

328

1441

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

155

464

3.33

41.76

1.3

1.1

41.65

20.14

iu/ml

0.70

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

744

4357

1.71

41.13

1.2

1.1

1.63

0.99

0.54

170

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

648

3651

1.78

41.05

7.4

6.0

12.22

11.78

mg/l

1.64

607

3365

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

114

282

4.03

40.69

1.0

—

(1616796) Gas panel - Central venous blood

968

6090

1.60

40.42

4.1

3.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2226

16482

1.37

40.32

5.1

4.2

24.29

24.25

mmol/l

0.24

2201

16289

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1726

23599

0.71

39.91

1.6

1.7

3.38

3.49

mmol/l

3.96

1177

16010

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1291

8698

1.49

39.50

3.3

2.6

3.62

3.58

g/l

0.43

1238

8323

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

408

2005

2.03

39.29

1.2

1.1

—

(40761511) CBC panel - Blood by Automated count

28798

278166

1.30

39.15

21.7

13.6

—

75.44

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2413

18184

1.34

38.94

10.7

9.7

93.76

93.99

0.95

2405

18122

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

275

1158

2.37

38.90

4.1

4.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

583

3250

1.80

38.31

2.4

2.5

1.82

1.16

g/24h

3.01

358

1887

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2401

18128

1.34

38.23

10.6

9.6

1.28

1.33

1.70

2386

18022

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

238

946

2.51

38.20

3.2

2.7

0.61

mmol/l

0.78

238

946

(3026389) Candida sp identified in Specimen by Organism specific culture

730

4347

1.68

37.95

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

687

4036

1.71

37.56

1.1

3.99

2.75

1.87

677

(3005011) Chlamydia sp Ab [Titer] in Serum

117

313

3.72

37.45

1.4

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

473

2496

1.90

37.07

4.0

3.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1317

9025

1.47

36.99

2.8

2.3

94.69

93.68

0.84

1265

8683

(3042733) HLA Ab [Presence] in Serum

221

862

2.56

36.92

4.1

5.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

252

1048

2.40

36.69

2.1

2.2

27.97

29.26

0.81

234

1003

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

371

1812

2.05

36.37

1.4

13.25

12.68

u/l

0.72

358

1759

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

120

334

3.58

36.25

1.7

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

293

1311

2.23

36.00

1.3

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

293

1311

2.23

36.00

1.3

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

890

5646

1.58

35.89

3.1

2.5

16.07

16.50

4.09

875

5519

(3006245) CD3-CD19+ cells/cells in Blood

257

1097

2.34

35.30

2.6

2.4

8.37

10.68

2.75

227

1032

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1431

10088

1.43

34.55

4.6

3.4

796.30

2060.99

u/ml

0.98

1241

8664

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7982

69709

1.18

34.45

2.6

2.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

343

1662

2.06

34.39

4.3

2.0

97.99

99.04

0.20

330

1556

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2308

17594

1.33

34.28

10.9

9.9

0.66

0.64

1.28

2293

17503

(3019225) pH of Specimen

3296

26362

1.27

33.95

4.6

4.2

7.36

0.27

2729

18574

(3024354) Oxygen [Partial pressure] in Venous blood

2968

23438

1.28

33.89

4.0

3.4

4.47

4.56

kpa

2.04

2888

22839

(3042111) Morphology [Interpretation] in Bone marrow Narrative

706

4309

1.64

33.41

1.5

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

136

432

3.14

33.36

1.4

662450.00

7857.17

u/ml

0.47

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

253

3.86

33.06

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2436

18808

1.31

32.98

9.8

8.1

24.90

24.82

mmol/l

0.52

2417

18668

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

883

5734

1.54

32.15

4.4

3.4

441.31

946.43

u/ml

1.38

791

5194

(42529406) Shigella sp [Presence] in Stool by Culture

1131

7736

1.47

32.07

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6238

53656

1.19

31.61

4.2

3.9

354.89

417.57

ng/l

0.58

4829

40582

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

531

3054

1.74

31.42

2.3

2.5

31.76

25.94

iu/ml

0.37

325

(3014765) Yersinia sp identified in Stool by Organism specific culture

1126

7726

1.46

31.41

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2156

16475

1.32

31.40

10.7

9.6

24.45

24.31

mmol/l

1.22

2111

16112

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3413

27656

1.25

31.30

3.0

2.5

49.76

48.58

u/l

0.04

2947

23361

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1119

7676

1.46

31.26

1.2

—

(3036489) Thrombin time

1499

10864

1.39

30.83

2.6

2.1

20.90

21.04

0.36

1306

9619

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

23112

219646

1.17

30.68

4.8

4.6

14.95

14.73

pmol/l

37.36

21557

202847

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1205

8420

1.44

30.53

3.0

2.6

200.18

189.56

3.70

1145

8004

(3009015) Lactate [Moles/volume] in Synovial fluid

259

3.69

30.45

1.4

1.2

5.81

6.09

mmol/l

0.15

117

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2067

15780

1.32

30.28

10.6

9.7

15.64

16.04

9.38

1997

15245

(3019174) dRVVT (LA screen)

204

4.05

30.00

1.2

—

(21494755) Public health laboratory ask at order entry panel

2098

26753

0.76

29.97

1.3

—

(3013512) EKG study

10443

93985

1.15

29.62

3.7

3.6

0.67

0.75

0.36

235

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

493

2825

1.75

29.58

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

237

3.78

29.57

1.1

230.10

312.15

u/ml

0.94

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2766

22016

1.27

29.44

2.3

6.85

7.08

ug/l

0.17

2415

19207

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1102

7640

1.45

29.13

1.2

4.43

3.83

0.98

101

1073

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

104

308

3.36

28.67

3.7

9.8

0.49

0.40

umol/l

0.49

288

(3027315) Oxygen [Partial pressure] in Blood

849

5658

1.50

27.43

4.4

3.8

8.49

8.68

kpa

2.69

832

5523

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

371

3.03

26.31

1.8

1.5

—

(3012501) Base excess in Blood by calculation

838

5629

1.49

26.06

4.4

3.8

2.42

2.56

mmol/l

0.76

601

3807

(3013290) Carbon dioxide [Partial pressure] in Blood

838

5631

1.49

26.02

4.4

3.8

4.97

5.01

kpa

0.95

821

5497

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

236

1106

2.13

25.99

3.1

3.3

1.05

1.37

2.54

236

1106

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3487

28864

1.22

25.95

1.9

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3785

31591

1.22

25.94

2.0

2.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1617

12182

1.34

25.92

5.3

4.8

1.58

1.63

1.31

1536

11576

(3001964) Herpes simplex virus Ag [Presence] in Specimen

175

725

2.41

25.87

1.4

1.5

—

(44806071) Cardiolipin IgM antibody measurement

107

347

3.07

25.46

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

1198

8643

1.39

25.31

4.1

1.35

1.38

mmol/l

0.55

1169

8484

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

338

1817

1.86

25.18

1.3

15.80

14.01

u/l

0.78

317

1672

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

26497

255603

1.18

24.92

5.9

5.6

1.89

mu/l

0.01

24939

238201

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

148

579

2.55

24.76

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1222

8885

1.38

24.64

1.4

282.82

275.49

ug/g

0.58

707

5135

(3044009) aPTT.lupus sensitive (LA screen)

212

3.66

24.56

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1429

10656

1.35

24.53

2.2

2.0

—

(3034426) Prothrombin time (PT)

192

849

2.25

24.47

1.3

1.2

28.44

28.07

0.41

192

849

(3000330) Specific gravity of Urine by Test strip

1785

13783

1.30

23.98

3.8

3.4

1.02

ratio

1.21

1640

12315

(3024932) HLA-DR beta [Type]

181

794

2.27

23.53

1.1

—

(3024471) HLA-A [Type]

184

814

2.25

23.45

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

788

5348

1.48

23.32

1.7

1.9

4.71

5.11

mmol/24h

3.23

713

4766

(3045716) Anion gap in Serum or Plasma by calculation

474

2870

1.65

23.29

3.2

3.0

10.18

10.79

mmol/l

3.12

467

2831

(4024509) Urine culture

1692

13036

1.31

23.10

2.1

1.9

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

160

674

2.37

22.86

1.7

1.9

31.85

37.36

u/l

0.20

143

615

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

457

2762

1.65

22.64

1.3

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

350

1967

1.78

22.60

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

140

559

2.49

22.50

2.9

2.5

825.74

126.64

ug/l

0.45

140

559

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1746

13558

1.30

22.47

4.1

4.0

47.64

47.89

0.16

1718

13382

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1309

9782

1.34

22.16

2.0

1.9

—

(3028271) Lactate [Moles/volume] in Capillary blood

635

4167

1.52

22.15

2.1

1.8

1.67

1.73

mmol/l

0.73

622

4053

(3009508) Creatinine [Moles/volume] in Urine

10592

96764

1.13

22.15

4.1

3.4

7.20

7.44

mmol/l

6.59

9232

81965

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

104

367

2.82

21.37

1.4

1.5

206417.83

229808.39

nmol/l

0.05

302

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

397

2350

1.69

21.33

1.4

1.3

483.20

485.67

u/l

0.01

373

2234

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

159

3.88

21.26

3.6

2.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1678

0.25

21.21

11.0

15.0

831.14

2180.64

nmol/l

0.78

1620

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

342

1949

1.75

21.09

1.2

—

(3047181) Lactate [Moles/volume] in Blood

1101

8078

1.37

21.01

6.0

5.5

1.30

1.31

mmol/l

0.04

970

7166

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1850

14595

1.28

21.00

3.5

3.1

1.21

1.26

1.20

1843

14530

(3000060) B lymphocytes [#/volume] in Blood

183

848

2.15

20.86

2.3

0.16

0.42

e9/l

1.59

418

(3017569) Oxygen content in Arterial blood

262

1382

1.89

20.81

2.4

2.2

15.84

15.83

0.02

262

1382

(3012516) Albumin [Mass/volume] in Urine

9820

89579

1.13

20.64

4.1

3.5

62.31

44.76

mg/l

7.52

6439

55687

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1833

14477

1.27

20.61

3.5

3.0

0.65

0.62

3.74

1828

14433

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1238

9316

1.33

20.01

1.3

225.29

223.56

miu/ml

0.06

491

4331

(3007461) Platelets [#/volume] in Blood

30060

294287

1.27

19.76

43.0

23.0

262.59

254.12

e9/l

92.20

29797

288278

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1164

8705

1.34

19.63

3.3

3.1

0.34

0.36

iu/ml

0.76

636

4759

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

789

5549

1.42

19.39

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

789

5549

1.42

19.39

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

550

3607

1.52

19.31

3.3

2.1

14.66

6.60

umol/l

5.86

420

2619

(3020682) Albumin/Creatinine [Ratio] in Urine

9948

91096

1.12

19.26

4.9

4.1

11.33

8.29

mg/mmol

5.53

6396

55387

(3035941) MCH [Entitic mass]

30062

294374

1.26

19.24

42.6

22.9

30.49

30.25

98.76

29942

291369

(3024731) MCV [Entitic mean volume] in Red Blood Cells

30062

294378

1.26

19.21

42.7

22.9

92.20

90.90

307.65

29944

291371

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

30062

294392

1.26

19.10

43.4

23.4

39.99

40.65

15.47

29940

291276

(3003434) Protein [Mass/volume] in Pleural fluid

532

3474

1.53

19.06

1.5

1.4

33.73

33.10

g/l

0.53

501

3149

(3026361) Erythrocytes [#/volume] in Blood

30062

294403

1.26

19.02

42.8

23.0

4.38

4.49

e12/l

284.64

29725

287440

(3010813) Leukocytes [#/volume] in Blood

30065

294443

1.26

18.96

42.9

23.0

6.86

6.69

e9/l

34.50

29731

287475

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

194

954

2.03

18.95

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

250

1340

1.86

18.95

1.7

1.8

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

4.70

18.91

1.0

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

994

7301

1.36

18.87

4.3

4.4

3.86

mmol/l

0.06

985

7242

(3000963) Hemoglobin [Mass/volume] in Blood

30063

294455

1.26

18.69

43.2

23.1

132.54

134.86

g/l

165.02

29939

291517

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

249

1340

1.85

18.65

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

249

1340

1.85

18.65

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

249

1340

1.85

18.65

1.7

1.8

—

(4195642) Thrombophilia screening test

601

4047

1.48

18.59

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

101

4.43

18.43

1.1

1.3

0.06

0.08

g/l

0.57

(3023183) Ammonium ion [Moles/volume] in Plasma

823

5885

1.40

18.41

3.3

2.6

31.70

33.96

umol/l

2.55

767

5277

(3036782) Glucose [Moles/volume] in Pleural fluid

402

2483

1.62

18.36

1.4

1.3

5.86

6.36

mmol/l

3.08

369

2307

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2661

22164

1.21

18.31

1.5

—

(3003181) Sodium [Moles/volume] in Urine

744

5244

1.42

18.09

1.5

1.4

60.70

61.41

mmol/l

0.19

613

4140

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

235

1259

1.86

17.87

1.3

1.2

13.64

9.83

mm/h

3.08

235

1259

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

497

3247

1.53

17.80

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

600

4085

1.47

17.59

1.1

120.32

118.82

0.52

550

3703

(3007930) Methemoglobin/Hemoglobin.total in Blood

1421

11102

1.28

17.44

5.7

5.0

0.87

0.88

0.24

1345

10522

(3004716) Salmonella sp identified in Stool by Organism specific culture

1726

13825

1.25

17.22

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

619

4260

1.45

17.17

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

272

1551

1.75

16.86

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

212

1123

1.88

16.74

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

541

3656

1.48

16.50

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

213

1136

1.87

16.48

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2082

17101

1.22

16.46

4.0

3.4

125.67

129.28

g/l

11.29

2020

16636

(3004451) EKG impression Narrative

256

1445

1.77

16.45

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

550

3748

1.47

16.09

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

479

3176

1.51

16.06

1.9

1.8

89.72

89.84

0.19

471

3127

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

189

3.21

15.84

1.0

1.1

41.61

8.80

iu/ml

2.04

(3039000) Anion gap in Blood by calculation

754

5453

1.38

15.83

7.2

6.5

11.12

11.25

mmol/l

0.55

685

4927

(3018572) Chloride [Moles/volume] in Blood

754

5454

1.38

15.81

7.2

6.5

104.93

105.05

mmol/l

0.29

685

4929

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

171

865

1.97

15.54

1.1

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

5.22

15.42

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

536

3672

1.46

15.28

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

186

975

1.90

15.22

1.2

1043.90

1016.10

titre

0.10

205

(3027273) Bicarbonate [Moles/volume] in Venous blood

1522

12207

1.25

15.02

3.9

3.5

25.39

25.29

mmol/l

0.54

1465

11815

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1258

9886

1.28

14.77

5.1

3.9

24.87

24.83

mmol/l

0.19

1171

9087

(3035880) pH of Pleural fluid

227

1281

1.77

14.66

1.3

7.40

7.41

0.53

152

907

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

182

961

1.89

14.59

1.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

182

961

1.89

14.59

1.9

2.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

793

10488

0.74

14.59

1.9

1.7

7.15

4.07

mg/l

5.08

658

7790

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

511

3505

1.46

14.51

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

183

972

1.88

14.42

1.9

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

509

3493

1.45

14.42

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

511

3510

1.45

14.40

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

108

472

2.28

14.38

1.2

1.4

43.86

381.36

titre

—

(21494434) Karyotype in Bone marrow

363

2325

1.56

14.34

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

388

2.41

14.26

1.9

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

233

1337

1.74

14.22

3.0

1.8

1.95

umol/l

0.05

219

1226

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1447

11618

1.25

14.16

1.7

0.30

0.31

mg/l

0.39

612

5445

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

462

3123

1.48

14.15

1.2

1.1

95.62

96.66

0.35

428

2931

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

241

1402

1.71

14.01

1.9

1.8

1.72

2.60

u/field

1.74

170

992

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

253

2.75

13.92

3.3

2.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

238

1383

1.71

13.90

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

325

2046

1.58

13.86

1.4

1.5

20.93

25.43

u/ml

0.91

385

(3023199) Leukocytes [#/volume] in Pleural fluid

459

3114

1.47

13.82

1.5

2836.86

3283.59

e6/l

0.29

316

2188

(3025577) Chromium [Mass/volume] in Blood

240

1403

1.70

13.72

2.2

2.28

2.47

ug/l

0.37

193

1165

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

166

869

1.90

13.70

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

246

1449

1.69

13.67

2.2

3.77

3.79

ug/l

0.02

222

1339

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

219

1255

1.74

13.46

1.1

—

0.50

—

(3045142) Bone marrow Pathology biopsy report

444

3023

1.47

13.15

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

998

7742

1.29

13.03

1.1

4.53

6.25

eliau/ml

0.75

1006

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

218

1260

1.72

13.01

3.1

1.7

27.98

29.25

umol/l

0.99

213

1180

(4034850) Laboratory test

1075

8421

1.28

12.99

12.7

9.8

—

(3046861) Legionella sp Ag [Presence] in Urine

141

3.31

12.92

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

860

6577

1.31

12.52

1.2

1.3

3.67

3.73

mmol/l

0.96

819

6225

(3045788) Cell count panel - Pleural fluid

378

2518

1.50

12.52

1.4

1.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

175

3.01

12.46

1.2

1.1

24.88

28.87

u/ml

0.19

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

175

3.01

12.46

1.2

1.1

17.24

24.90

u/ml

0.67

(40768806) Pleura Pathology biopsy report

389

2619

1.48

12.23

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

147

775

1.89

11.95

1.1

1.3

17.13

16.77

umol/l

0.39

136

660

(3049717) Cytology report of Urine Cyto stain

1183

9469

1.25

11.94

2.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

254

1566

1.62

11.90

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

949

7403

1.28

11.89

1.3

1.4

590.53

533.35

mg/l

0.58

917

7086

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

770

9927

0.76

11.84

1.1

0.56

0.63

ratio

2.82

1225

(3023383) Lactate [Moles/volume] in Pleural fluid

138

715

1.92

11.83

1.3

4.18

3.35

mmol/l

1.58

125

658

(3009466) Valproate [Moles/volume] in Serum or Plasma

270

4163

0.64

11.83

4.1

5.5

353.66

364.90

umol/l

0.73

235

3657

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

148

786

1.87

11.77

1.6

0.32

0.40

ug/l

2.50

116

557

(4035726) Immunohistochemistry procedure

2867

24923

1.16

11.75

1.4

—

(3047189) Immunofixation for 24 hour Urine

198

1150

1.71

11.67

1.3

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

373

2.27

11.32

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

276

1761

1.56

11.21

1.2

1.3

83.08

56.59

titre

0.61

129

(3036603) Volume of Urine

320

2113

1.51

11.12

1.5

1.6

1920.44

1972.27

0.47

313

2067

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3322

29297

1.14

11.06

4.2

26.99

23.77

ug/l

0.17

2642

23611

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

281

1809

1.55

10.99

1.3

734.55

483.67

titre

0.22

128

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

362

2458

1.47

10.97

1.2

103.72

111.94

pmol/l

2.69

362

2458

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2851

32091

0.87

10.78

1.6

1.7

—

6.83

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

663

4999

1.32

10.76

1.1

18.85

14.83

au/ml

0.68

135

1257

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

844

6583

1.28

10.63

1.4

1.5

1465.53

2434.39

e6/l

0.44

677

5165

(40761539) Cells [Type] in Urine sediment by Light microscopy

121

623

1.93

10.62

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

220

2.62

10.61

1.1

79.45

96.58

titre

1.36

220

(3028308) Erythrocytes [#/volume] in Pleural fluid

399

2779

1.43

10.59

1.4

1.5

43443.21

49164.68

e6/l

0.26

207

1570

(3022493) Free Hemoglobin [Mass/volume] in Plasma

201

1205

1.66

10.58

1.7

4.3

1093.96

1860.67

mg/l

0.30

148

865

(3041672) Baker's yeast Ab [Presence] in Serum

149

3.00

10.58

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

227

1404

1.61

10.56

2.3

1.9

7.78

8.11

mmol/l

0.76

227

1404

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

837

10517

0.78

10.53

1.1

1.54

g/l

0.01

837

10508

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3566

31694

1.13

10.51

7.7

6.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

108

538

2.00

10.43

2.2

2.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.87

10.42

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

443

2.09

10.15

1.8

2.9

81.30

37.67

mg/l

1.02

105

(3035320) C reactive protein [Mass/volume] in Body fluid

335

2277

1.47

10.14

3.1

2.6

28.94

28.19

mg/l

0.14

265

1615

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

828

6501

1.27

9.92

1.3

1.4

46.08

34.62

e6/l

0.30

611

4809

(3027456) Digoxin [Moles/volume] in Serum or Plasma

681

5220

1.30

9.85

3.4

3.3

0.83

0.80

nmol/l

0.92

554

4211

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

120

637

1.87

9.65

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2427

21149

1.15

9.60

1.2

120.65

142.08

u/ml

2.12

908

8018

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

414

2958

1.40

9.56

1.1

80.20

67.19

au/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

166

2.76

9.31

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1059

1.65

9.21

1.4

2.1

39.39

40.23

g/l

1.11

176

1059

(3016038) Potassium [Moles/volume] in Urine

286

1931

1.48

9.02

1.2

31.43

34.14

mmol/l

1.43

242

1681

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

326

2.20

8.99

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

486

1.97

8.93

1.2

1.79

1.67

mmol/l

0.35

300

(3020618) Glucose [Moles/volume] in Synovial fluid

3.52

8.82

1.1

1.0

4.90

4.93

mmol/l

0.02

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

266

2.32

8.80

1.1

1.2

1.36

1.75

iu/ml

1.27

143

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

4.16

8.80

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

122

674

1.80

8.69

1.3

467.62

255.40

ug/l

0.32

372

(3012565) Volume of 24 hour Urine

211

1347

1.56

8.68

1.7

2.2

2109.15

1939.53

1.47

187

1210

(3020717) Zinc [Moles/volume] in Serum or Plasma

253

1682

1.50

8.63

1.4

1.5

19.48

23.92

umol/l

1.85

237

1561

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

389

5266

0.73

8.54

2.8

3.8

34.15

39.14

u/ml

0.19

374

5089

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

515

6690

0.76

8.50

1.5

1.20

1.19

ratio

0.04

290

4040

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

515

6690

0.76

8.50

1.5

0.94

0.95

ratio

0.10

288

4013

(3024891) Influenza virus A+B Ag [Presence] in Specimen

942

7647

1.23

8.47

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

513

6664

0.76

8.47

1.5

1.17

1.16

ratio

0.07

286

3987

(3030313) Adrenal Ab [Titer] in Serum

259

2.30

8.42

1.1

15.83

28.50

titre

—

(3020650) Glucose [Presence] in Urine

158

949

1.66

8.38

1.9

1.6

0.02

0.05

estimate

0.72

158

949

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

322

2258

1.42

8.35

1.1

279.02

259.03

mg/l

0.52

289

2004

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

310

2159

1.43

8.35

1.9

2.0

1.95

3.03

u/field

0.47

166

1207

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

261

1761

1.48

8.30

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

508

6583

0.76

8.25

1.4

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

264

1789

1.47

8.22

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

413

5504

0.74

8.19

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

330

2339

1.41

8.07

1.2

44.27

41.38

mg/l

0.40

277

1985

(3040151) Glucose [Moles/volume] in Capillary blood

427

3159

1.35

8.02

4.6

8.4

7.26

7.39

mmol/l

0.33

364

2599

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

317

2241

1.41

7.88

1.3

2.32

2.11

mmol/l

0.98

298

2080

(3043238) Trisomy 21 risk [Likelihood] in Fetus

427

5627

0.75

7.86

1.6

—

(3005033) Fetal Nuchal fold Thickness US

408

5411

0.75

7.85

1.5

1.25

1.26

0.17

288

3917

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

26058

254708

1.09

7.84

6.4

6.3

38.22

39.09

mmol/mol

50.24

24767

238939

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

552

7023

0.78

7.80

1.5

61.08

61.88

ug/l

0.14

449

5815

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

371

2699

1.37

7.78

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

190

2.46

7.66

4.7

4.0

2.06

2.20

mg/l

0.15

160

(3008295) Osmolality of Serum or Plasma

414

3075

1.34

7.60

1.4

1.5

276.56

278.76

mosm/kgh2o

1.16

334

2314

(3003129) Base excess in Capillary blood by calculation

435

3255

1.33

7.60

2.7

2.2

0.62

mmol/l

0.01

421

3127

(3024928) Oxygen saturation in Venous blood

867

7063

1.23

7.59

4.0

3.3

62.14

61.97

0.08

844

6821

(40762814) Titanium [Mass/volume] in Blood

397

1.98

7.58

2.4

2.5

4.93

3.40

ug/l

0.67

150

(3001019) Free T4 and TSH panel - Serum or Plasma

1269

14770

0.85

7.51

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

122

706

1.72

7.48

1.2

7.12

12.43

pmol/l

2.40

265

(1617658) Protocol used for examination of sentinel lymph nodes

152

2377

0.63

7.31

1.1

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12319

117477

1.07

7.30

2.0

1.9

1.34

1.35

mmol/l

1.84

10471

99030

(3002619) Bacteria identified in Specimen by Culture

126

743

1.69

7.23

1.5

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

122

714

1.70

7.20

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

248

1708

1.45

7.17

1.7

1.5

9.17

8.70

ug/l

0.10

224

1565

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

192

1256

1.52

7.17

2.2

2.6

60.39

166.67

ug/l

0.85

187

1193

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

449

3406

1.31

7.15

2.5

2.0

26.43

25.29

mg/l

0.18

182

1228

(3019230) Fractional oxyhemoglobin in Venous blood

743

5999

1.24

7.11

4.2

3.2

62.32

62.09

0.11

743

5978

(3026051) Granulocytes/Leukocytes in Pleural fluid

534

1.81

7.09

1.4

30.47

21.90

1.85

447

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.09

7.02

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

319

2307

1.38

6.99

1.2

1.3

0.82

1.78

u/ml

2.15

179

1333

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

112

2.84

6.94

1.0

0.15

0.07

u/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1160

9798

1.18

6.93

1.6

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

701

1.69

6.88

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1059

12413

0.84

6.84

1.6

995.77

1012.61

mu/l

0.23

877

10389

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

710

1.68

6.83

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

1687

0.58

6.83

12.9

13.4

0.64

0.62

mmol/l

0.28

1557

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

385

1.94

6.82

4.0

5.5

48.85

42.87

ug/min

0.35

289

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

297

2134

1.39

6.79

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

400

1.91

6.76

1.5

1.4

76.67

323.16

ng/l

0.60

251

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

167

1075

1.55

6.74

1.3

1.2

0.31

0.30

g/l

0.65

135

868

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

19588

189858

1.06

6.70

4.3

3.3

53.94

46.02

u/l

23.28

18610

178905

(3032773) Endomysium IgG Ab [Titer] in Serum

388

2913

1.33

6.69

1.1

—

61.25

titre

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

174

1143

1.52

6.43

1.1

93.44

97.54

0.87

137

903

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

511

4004

1.27

6.40

1.3

1.4

533.43

351.46

pmol/l

0.44

449

3434

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

252

2.13

6.38

1.1

1.0

0.03

0.04

u/ml

0.26

252

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

246

2.14

6.35

1.2

0.30

0.37

u/ml

0.09

(44813793) Dust mix specific IgE antibody measurement

295

2147

1.37

6.27

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

199

1353

1.46

6.22

1.1

1.3

54.58

63.18

0.47

156

(3050794) Legionella sp Ab [Presence] in Serum

229

2.17

6.20

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.22

6.19

1.1

1.0

0.21

g/l

0.16

(3000919) Neutrophils/Leukocytes in Pleural fluid

107

632

1.68

6.18

1.4

31.00

20.14

3.01

578

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.93

6.09

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

369

2796

1.31

6.01

3.5

3.4

16.90

13.94

index

1.99

211

1559

(40765096) Chromosome analysis panel by Banding

126

782

1.60

6.01

1.2

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

221

2.16

5.90

1.1

1.2

10.45

9.92

mg/l

0.14

202

(3001893) Eosinophils/Leukocytes in Pleural fluid

115

702

1.63

5.87

1.4

2.58

2.88

0.17

604

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

129

2.54

5.85

1.0

0.16

0.13

u/ml

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

235

2.12

5.84

1.6

0.26

1.85

mg/l

6.45

165

(3011985) Renin [Units/volume] in Plasma

545

4356

1.25

5.81

1.5

52.71

60.13

mu/l

0.54

498

3903

(4015189) Microbial culture of sputum

106

637

1.66

5.77

2.4

2.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

227

1608

1.41

5.72

1.1

1.21

1.11

u/l

0.64

659

(3010937) Rubella virus Ab [Presence] in Serum

173

2.30

5.71

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

155

1021

1.51

5.71

1.4

1.5

14.68

14.89

pmol/l

0.22

130

854

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

303

2250

1.34

5.70

1.7

1.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1394

0.58

5.69

3.5

6.0

34.67

3568.40

u/ml

—

229

(3019768) Coxiella burnetii Ab [Presence] in Serum

155

2.37

5.68

1.0

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.43

5.65

1.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

227

2.10

5.54

1.6

1.88

2.53

mg/l

0.41

169

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

227

2.10

5.54

1.6

0.77

1.26

mg/l

0.66

151

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

227

2.10

5.54

1.6

1.41

0.85

mg/l

0.25

162

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

227

2.10

5.54

1.6

3.79

2.49

mg/l

0.47

165

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

227

2.10

5.54

1.6

3.02

2.06

mg/l

0.34

158

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

227

2.10

5.54

1.6

5.13

4.02

mg/l

0.27

157

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

227

2.10

5.54

1.6

1.10

2.25

mg/l

1.74

178

(40757494) Bilirubin.total [Moles/volume] in Blood

192

1331

1.44

5.48

2.5

2.1

12.71

29.80

umol/l

2.68

130

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

228

2.09

5.48

1.6

2.12

1.72

mg/l

0.19

149

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

228

2.09

5.48

1.6

1.66

1.64

mg/l

0.01

172

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

656

1.62

5.41

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

405

1.79

5.31

1.3

1.2

0.81

1.49

mmol/l

0.87

263

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

348

1.86

5.30

1.3

47.70

158.50

u/l

0.66

249

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

219

2.09

5.24

1.4

1.3

1.16

1.53

ml/s/173m2

0.45

149

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

150

1004

1.49

5.16

1.3

1.2

113.45

110.77

0.50

130

913

(3002079) Sodium [Moles/time] in 24 hour Urine

194

1366

1.41

5.12

1.4

1.2

146.70

158.91

mmol/24h

1.46

194

1366

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

403

1.78

5.11

1.3

35.57

41.54

mg/l

0.62

344

(3005532) Lymphocytes/Leukocytes in Pleural fluid

127

827

1.53

5.00

1.4

54.14

64.06

2.32

102

692

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

132

867

1.51

4.99

1.2

1.3

30.48

20.80

0.65

138

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

224

2.04

4.95

1.2

0.36

0.55

iu/ml

1.12

119

(3028707) Methadone [Presence] in Urine by Screen method

400

4988

0.79

4.95

2.5

2.6

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

242

1778

1.35

4.95

1.3

1.2

0.56

0.66

ratio

1.60

146

1023

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

272

2035

1.33

4.94

1.1

21.14

19.19

u/ml

0.26

826

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

251

1856

1.35

4.93

1.7

1.9

88.23

101.03

ng/l

1.64

251

1851

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

565

1.64

4.92

1.3

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

112

714

1.56

4.86

1.2

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

106

2.53

4.79

1.0

1.1

0.33

0.62

umol/24h

0.57

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

143

2.29

4.75

1.0

1.2

1.04

1.20

u/field

0.58

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

141

950

1.48

4.74

1.1

93.68

90.24

0.63

429

(3017315) Amylase [Enzymatic activity/volume] in Urine

209

1513

1.37

4.72

1.3

289.56

332.66

u/l

0.30

194

1403

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

341

1.81

4.69

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

139

936

1.48

4.69

1.1

97.59

90.28

1.20

430

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

327

1.82

4.68

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

337

4251

0.79

4.64

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

273

1.89

4.56

1.1

21.75

21.14

u/l

0.08

182

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

396

3147

1.25

4.55

1.3

—

(4146454) Self-monitoring of blood glucose

227

3005

0.75

4.52

2.7

2.8

—

(3018133) Calcium [Moles/volume] in Urine

586

1.60

4.52

1.7

2.0

2.64

2.78

mmol/l

0.31

533

(3035082) Kappa light chains [Mass/volume] in Urine

2.78

4.48

1.0

1.1

0.02

0.14

g/l

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

268

1.89

4.47

1.5

1.4

64.54

73.20

1.04

226

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

557

1.61

4.46

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

188

2.06

4.36

1.2

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

709

8247

0.85

4.33

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

27205

267539

1.07

4.32

5.2

5.1

4.62

4.68

mmol/l

21.64

25727

251369

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

269

3454

0.77

4.30

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

142

978

1.44

4.30

1.1

1.2

117.72

108.69

1.62

132

893

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

140

967

1.44

4.19

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

274

2105

1.30

4.18

1.2

351.86

366.71

nmol/l

0.59

230

1776

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

495

4068

1.21

4.18

1.1

4.24

2.94

eliau/ml

0.71

173

1950

(3024316) Viscosity of Plasma

120

2.32

4.17

1.1

1.7

1.48

1.57

mpas

0.42

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

198

1453

1.36

4.16

1.4

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

230

1733

1.32

4.06

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

515

4274

1.20

3.95

1.3

0.60

1.88

nmol/l

1.51

494

4123

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

524

4357

1.20

3.94

1.2

1.3

0.19

0.22

nmol/l

0.22

271

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.00

3.91

1.1

248.75

257.34

u/ml

0.06

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3611

33661

1.07

3.91

1.7

1.8

1.51

1.44

7.24

3112

29697

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

123

844

1.45

3.85

1.4

1.3

149.73

127.81

nmol/l

0.56

601

(4198724) Urine methamphetamine measurement

1281

0.65

3.83

1.7

2.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

194

1440

1.34

3.82

1.6

2.0

163.12

146.31

1.68

181

1362

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

645

1.51

3.78

7.5

7.9

5.87

5.97

kpa

0.43

575

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

175

1282

1.36

3.76

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

175

1282

1.36

3.76

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

390

3174

1.22

3.69

1.2

55.29

35.82

nmol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

108

2.30

3.69

1.2

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

102

2.34

3.67

2.5

4.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.98

3.64

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

290

2290

1.26

3.62

3.6

2.9

90.01

45.21

mg/l

1.14

227

1589

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

27532

271132

1.07

3.61

5.8

5.7

2.66

2.74

mmol/l

54.42

25957

253789

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2144

19642

1.09

3.61

3.1

3.5

4.42

4.49

pmol/l

1.88

1931

17666

(3026692) Albumin [Mass/volume] in Peritoneal fluid

104

701

1.48

3.59

1.3

1.4

10.67

13.76

g/l

2.64

541

(3023410) Appearance of Cerebral spinal fluid

371

3014

1.23

3.58

1.4

1.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.84

3.57

1.0

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

117

2.21

3.50

1.0

1.1

200.33

521.33

u/l

1.60

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

6.11

3.48

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3824

40206

0.94

3.46

3.1

3.2

0.71

0.77

ug/l

2.87

2550

25836

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

306

2448

1.24

3.43

3.0

2.8

—

(3020393) Adenovirus Ag [Presence] in Stool

308

1.71

3.43

1.5

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

306

3745

0.81

3.35

1.3

1.4

3.28

3.70

ug/l

0.37

262

3246

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

434

1.58

3.30

1.1

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

179

1347

1.32

3.28

1.8

2.1

113.20

135.49

umol/l

0.42

102

672

(3006969) Lambda light chains [Mass/volume] in Urine

2.52

3.24

1.0

1.2

0.01

0.07

g/l

—

(3016750) Collection duration of Urine

187

1421

1.31

3.20

2.0

2.3

499.64

498.71

min

0.04

139

1071

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

318

1.66

3.09

1.3

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

27008

266041

1.06

3.08

5.1

5.0

1.52

1.48

mmol/l

40.74

25433

248591

(3006576) Bicarbonate [Moles/volume] in Blood

116

825

1.40

3.07

5.8

6.4

23.87

25.25

mmol/l

2.82

101

752

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

163

1224

1.32

3.06

1.1

353.46

483.83

ng/l

0.24

331

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

475

1.53

3.05

2.1

1.7

1.30

1.12

nmol/l

—

(3045177) Copper [Moles/volume] in Urine

3.15

3.02

1.1

0.21

0.49

umol/l

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1035

0.66

3.00

2.6

3.1

28.78

28.62

umol/l

0.04

795

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

156

1169

1.33

2.98

2.1

2.5

32.91

53.66

umol/l

9.23

141

1009

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

345

1.61

2.96

1.5

1.4

11.60

12.94

0.19

180

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

308

3709

0.82

2.92

1.3

7.21

7.17

mmol/l

0.09

279

3261

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

127

2.03

2.90

1.3

1.6

0.18

0.10

u/l

0.17

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

134

2.00

2.89

1.1

—

(40768795) Lymph node Pathology biopsy report

350

2899

1.20

2.87

1.3

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

6.62

2.85

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

728

8174

0.88

2.85

2.3

2.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

142

1.96

2.83

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

156

1.91

2.83

1.1

1.0

2.54

2.98

u/l

0.14

(3038071) Oxygen [Partial pressure] in Mixed venous blood

574

1.46

2.80

7.4

7.8

6.07

5.54

kpa

0.74

574

(4281824) Cell count and differential, peritoneal fluid

284

3430

0.82

2.80

1.1

—

(3027008) Opiates [Presence] in Urine

1065

11685

0.90

2.78

1.8

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

218

1728

1.26

2.74

1.0

—

(3028300) Cannabinoids [Presence] in Urine

1070

11713

0.90

2.69

1.8

2.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

952

8525

1.11

2.66

1.9

2.0

4.82

11.05

iu/l

1.17

358

3554

(3000764) Benzodiazepines [Presence] in Urine

1063

11633

0.90

2.66

1.8

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1186

10742

1.10

2.65

2.1

2.3

5577.34

5555.19

u/l

0.01

418

4200

(3014271) Vancomycin [Susceptibility]

160

1226

1.30

2.65

3.1

2.9

—

(3016879) Cocaine [Presence] in Urine

987

10839

0.90

2.64

1.8

2.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

160

1.86

2.64

1.4

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

438

3729

1.17

2.64

1.2

1.3

0.22

0.20

nmol/l

0.28

337

2899

(40757373) Influenza virus identified in Isolate

484

1.48

2.63

1.8

1.6

—

(3018291) Platelet Ab [Presence] in Serum

3.12

2.62

1.4

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

131

1715

0.76

2.60

1.6

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

215

1714

1.25

2.59

1.1

3.56

6.34

nmol/l

0.62

320

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

106

2.06

2.57

1.4

1.0

0.06

0.05

mg/l

0.33

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

258

2100

1.22

2.57

1.3

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

111

1484

0.74

2.56

1.3

1.4

35.53

34.17

nmol/l

0.15

1350

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

273

3276

0.83

2.55

3.0

4.3

39.00

58.64

u/ml

1.40

268

3243

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1251

11391

1.09

2.52

1.6

18.22

17.24

u/ml

0.15

188

2759

(3001218) Citrate [Mass/time] in 24 hour Urine

2.84

2.52

1.3

1.6

209.67

447.83

mg/24h

3.34

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

820

7310

1.12

2.51

1.2

1.3

—

(3041184) Isoniazid [Presence] in Urine

3.44

2.46

1.9

2.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

379

1.52

2.44

1.2

1.1

—

(3012898) Urea [Moles/volume] in Urine

277

1.61

2.44

1.2

1.4

167.68

167.72

mmol/l

0.00

248

(3027944) Amphetamines [Presence] in Urine

1059

11529

0.91

2.41

1.8

1.9

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.11

2.41

1.0

1.2

0.70

1.41

—

(3052592) Norovirus Ag [Presence] in Stool

502

1.45

2.41

1.4

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.12

2.40

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2910

27405

1.06

2.37

1.7

1.8

—

(4211845) Urine protein measurement

176

1389

1.26

2.35

4.9

2.9

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.09

2.34

1.0

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

344

0.49

2.34

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

162

1269

1.27

2.31

5.1

2.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

140

1077

1.29

2.30

1.3

1.4

79.96

186.67

nmol/24h

2.32

140

1077

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

137

1051

1.30

2.30

1.6

2.0

182.57

166.03

1.04

129

1000

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.07

2.28

1.0

1.1

1.00

1.33

u/field

0.42

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

149

1159

1.28

2.26

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

119

1.92

2.25

1.2

1.1

2434.54

4828.21

ng/l

0.74

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

371

1.50

2.24

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

155

1.80

2.24

1.7

1.5

268.07

318.31

umol/24h

0.94

155

(3029634) Reagin Ab [Titer] in Serum by VDRL

451

3907

1.15

2.22

1.7

2.1

9.44

8.62

titre

—

(40762365) Oxygen content in Arterial blood by calculation

413

1.47

2.20

3.3

2.9

15.88

14.65

ml/dl

1.93

385

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

293

1.56

2.20

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

325

2754

1.17

2.15

1.4

1.3

1.57

1.45

nmol/l

1.18

293

2481

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

225

1.63

2.14

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

465

1.43

2.14

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

108

1.93

2.11

1.2

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

532

5954

0.89

2.08

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

268

2243

1.19

2.07

1.1

10.19

7.81

iu/ml

0.50

590

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.43

2.07

4.3

4.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

602

5342

1.12

2.07

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

2.06

0.0

7.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

602

5344

1.12

2.05

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

275

1.55

2.05

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

115

1475

0.77

2.04

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

562

1.38

2.04

1.2

95.49

52.28

mg/l

0.25

396

(3004446) Plasmodium sp identified in Blood by Light microscopy

284

1.54

2.02

2.3

2.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

301

1.52

1.99

1.3

2.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.09

1.98

1.0

1.1

4.07

14.75

mg/l

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.21

1.97

4.7

5.3

8.78

4.78

mg/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

413

4678

0.88

1.97

1.0

1.1

3.05

4.16

u/ml

0.84

205

2325

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

635

1.35

1.94

1.1

1.2

82.04

87.11

0.35

170

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

119

1.84

1.92

1.0

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

637

1.34

1.91

1.1

62.33

74.88

1.23

165

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

188

0.42

1.91

1.0

1.1

1.27

1.24

mom

—

188

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

122

950

1.28

1.89

2.7

2.6

1.47

1.17

ug/l

0.77

117

909

(3027974) Hepatitis B virus e Ag [Presence] in Serum

172

1.68

1.88

1.4

1.6

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.84

1.84

1.0

0.38

0.07

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

25711

253615

1.04

1.83

4.4

4.3

1.26

1.28

mmol/l

8.91

24057

234852

(3033086) Enterovirus Ab [Titer] in Serum

1.96

1.81

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1622

17122

0.94

1.77

3.0

3.6

47.08

57.23

u/ml

0.99

1558

16563

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

586

1.34

1.76

1.3

1.19

1.18

mmol/l

0.44

586

(3008116) Ketones [Moles/volume] in Urine by Test strip

638

1.32

1.75

1.5

0.33

0.29

mmol/l

0.11

115

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

199

1.60

1.75

1.0

1.1

13.97

8.27

u/l

0.31

199

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

874

1.27

1.74

3.6

3.2

4.95

4.94

kpa

0.02

112

874

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

874

1.27

1.74

3.6

3.2

10.86

10.43

kpa

0.55

112

874

(3023430) Cat dander IgE Ab [Units/volume] in Serum

392

4406

0.88

1.71

1.0

1.1

2.45

4.71

u/ml

3.64

172

1974

(3028468) Fragments [Presence] in Blood by Light microscopy

3.82

1.70

1.0

2.2

—

(3032057) Clostridioides difficile [Presence] in Stool

556

1.34

1.69

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

313

1.46

1.69

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

138

1108

1.24

1.69

1.9

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

170

1.64

1.69

2.8

2.0

12.77

19.49

0.47

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

405

0.61

1.69

1.0

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

509

5623

0.90

1.66

1.1

4.16

4.79

u/ml

0.38

250

2945

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

268

2297

1.16

1.63

2.2

2.4

18.05

18.64

nmol/l

0.46

251

2180

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

158

1897

0.83

1.62

1.0

359.27

339.16

ng/l

0.28

108

1385

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.02

1.61

3.9

8.9

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

157

1.65

1.61

1.1

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.55

1.60

1.0

1.1

21.80

21.64

umol/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

348

3921

0.88

1.60

1.0

1.1

0.21

0.39

u/ml

0.79

108

1227

(3025018) Bordetella pertussis Ab [Titer] in Serum

246

2098

1.17

1.60

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

426

1.38

1.59

6.4

7.0

10.43

10.58

0.16

426

(3010726) Horse dander IgE Ab [Units/volume] in Serum

478

5269

0.90

1.53

1.1

1.07

1.78

u/ml

1.98

250

2667

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

215

1.53

1.52

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

108

856

1.25

1.52

1.9

—

(3004775) Volume in Urine collected for unspecified duration

227

1936

1.17

1.50

2.0

2.3

755.48

661.95

2.15

159

1334

(3000285) Sodium [Moles/volume] in Blood

508

1.33

1.49

1.3

1.2

138.54

138.11

mmol/l

0.40

420

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

2.84

1.49

1.2

3.7

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.14

1.48

1.3

2.5

2.07

3.44

mu/l

0.61

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.42

1.47

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.42

1.47

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.42

1.47

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.42

1.47

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.42

1.47

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.42

1.47

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

146

1.63

1.46

2.9

4.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

193

1.54

1.46

1.7

2.5

—

(3027874) Urate [Moles/volume] in Urine

1.80

1.44

1.2

1.1

1.96

1.72

mmol/l

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.71

1.42

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

26302

259816

1.03

1.42

5.0

5.1

5.81

5.90

mmol/l

28.77

24477

240428

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

396

1.36

1.1

1.0

0.09

0.31

u/ml

1.03

250

(3014178) Parietal cell Ab [Units/volume] in Serum

2.59

1.35

1.3

1.0

60.00

46.26

u/ml

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

133

1589

0.83

1.35

1.6

2.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

172

1453

1.18

1.32

2.8

2.1

208.14

201.44

u/l

0.59

172

1441

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

340

1.37

1.30

1.1

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

183

1.52

1.30

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

163

1904

0.85

1.30

1.0

41.79

41.19

ng/l

0.06

110

1363

(3002331) Protein [Mass/volume] in Peritoneal fluid

626

1.27

1.29

1.4

21.77

57.56

g/l

0.69

485

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

216

1.47

1.28

2.8

2.0

46.41

60.80

0.95

137

(3008401) Mugwort IgE Ab [Units/volume] in Serum

496

5398

0.91

1.28

1.1

0.53

1.03

u/ml

2.61

197

2374

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.76

1.27

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

163

1899

0.85

1.26

1.0

838.69

747.17

ng/l

1.31

110

1334

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

209

1.47

1.26

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

530

5744

0.92

1.25

4.6

3.3

28.26

26.65

mg/l

0.52

391

3968

(3018834) Bilirubin.total [Presence] in Urine by Test strip

157

0.51

1.24

2.1

3.8

—

0.00

estimate

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

171

1454

1.17

1.23

1.6

2.44

9.20

nmol/l

1.04

135

1207

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

170

1.52

1.22

1.1

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.03

1.20

1.5

1.6

1.19

2.03

mmol/24h

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

229

1.43

1.17

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

124

1.60

1.17

10.5

10.8

107.20

105.35

g/l

0.21

124

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

126

0.47

1.16

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1680

15944

1.05

1.16

1.9

2.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

197

1.46

1.15

1.5

25.05

39.02

1.26

133

(3013336) Amino acids [Identifier] in Serum or Plasma

1.79

1.12

1.5

2.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

190

1.46

1.12

2.2

2.3

0.71

0.65

ug/l

0.28

190

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

106

873

1.21

1.12

1.2

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.74

1.10

1.4

1.7

87.80

121.44

ug/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

556

5106

1.08

1.10

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

130

1094

1.18

1.09

1.2

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

696

7408

0.93

1.09

1.8

1.9

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

208

1.43

1.09

1.4

12.78

15.77

pmol/l

0.66

181

(3002256) Pathology report gross observation

3995

38623

1.03

1.09

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

679

7232

0.93

1.08

1.4

148.95

143.38

pmol/l

0.09

659

7066

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.37

1.08

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

184

1.46

1.07

1.1

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

276

1.37

1.07

1.3

33.14

22.92

1.01

214

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

148

1708

0.86

1.06

1.2

1.3

156.18

175.26

pmol/l

1.22

148

1708

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

539

1.25

1.04

1.3

1.1

—

(3007463) Buprenorphine [Presence] in Urine

124

0.48

1.04

1.0

7.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5298

53810

0.97

1.03

4.2

4.5

21.64

22.09

1.39

2577

25888

(3012494) Peanut IgE Ab [Units/volume] in Serum

773

1.21

1.03

1.1

2.69

7.51

u/ml

0.51

444

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

540

1.25

1.03

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

540

1.25

1.03

1.3

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.94

1.03

1.8

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

105

873

1.20

1.03

1.9

1.8

5837.61

10758.63

e6/l

0.68

443

(3023487) Leukocytes [#/volume] in Peritoneal fluid

121

1020

1.18

1.01

2.0

583.36

2594.09

e6/l

1.40

674

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.82

1.00

4.2

6.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

308

3376

0.91

0.99

1.6

2.0

30.24

25.12

ug/l

0.49

299

3305

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

455

0.74

0.96

1.1

1.2

74.82

68.43

ug/l

0.31

455

(3051101) Glucose [Moles/volume] in Cord blood

431

0.74

0.95

3.9

5.7

9.49

8.56

mmol/l

0.26

431

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

983

0.83

0.95

1.0

10.38

9.88

u/ml

0.07

618

(3025130) Human papilloma virus identified in Specimen

536

4954

1.08

0.94

2.0

1.8

—

(3020491) Glucose [Moles/volume] in Blood

222

1969

1.12

0.93

1.9

1.8

7.04

6.76

mmol/l

0.73

168

1423

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

365

3322

1.09

0.93

1.4

1.8

14880.00

2891.74

titre

—

109

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1162

11014

1.05

0.90

1.5

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

155

1756

0.88

0.90

1.7

1.8

—

(3022475) Manganese [Moles/volume] in Blood

181

0.60

0.89

1.4

1.2

0.16

umol/l

0.09

181

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.73

0.88

1.5

1.2

26.95

32.17

mg/24h

0.66

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

701

0.81

0.87

2.2

3.1

91.93

104.83

ng/l

0.36

337

(40761995) Spermatozoa Progressive [#/volume] in Semen

534

0.78

0.85

3.2

3.3

42.71

44.41

0.23

534

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

103

1.54

0.85

1.1

1.0

0.03

0.04

u/ml

0.45

103

(3020123) Porphyrins [Interpretation] in Serum or Plasma

169

1.41

0.84

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

533

0.78

0.84

6.5

6.6

9.60

8.69

0.41

533

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

416

4453

0.93

0.83

1.5

57.58

60.30

ug/l

0.71

416

4453

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

133

1507

0.88

0.80

1.3

1.4

5.50

5.73

mmol/l

1.63

124

1418

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.68

0.80

1.0

—

(3003694) ABO and Rh group [Type] in Blood

8269

80999

1.02

0.80

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

163

1.40

0.79

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

189

1.37

0.78

2.6

6.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

320

1.27

0.77

1.3

1.9

1.29

1.33

umol/l

0.17

234

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.61

0.76

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

111

958

1.15

0.75

1.0

0.48

0.68

u/ml

0.40

105

944

(3023511) Choriogonadotropin [Units/volume] in Urine

496

5252

0.94

0.75

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

299

2733

1.09

0.75

4.6

5.4

102.37

109.24

u/ml

0.07

913

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

166

1842

0.89

0.74

1.7

1.6

7.79

7.83

mmol/l

0.08

160

1771

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.83

0.73

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

617

6481

0.94

0.73

1.1

1.18

1.99

u/ml

2.32

317

3449

(40758358) Immune stain study

135

0.59

0.72

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

279

1.28

0.72

3.3

3.0

1.78

1.23

mg/l

0.54

201

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

637

5991

1.06

0.72

2.3

2.4

121.41

104.15

ug/min

0.43

353

3539

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1964

20106

0.97

0.71

2.2

2.3

13.32

12.66

nmol/l

3.02

1764

18215

(3013862) HLA-DP [Type]

108

1.47

0.71

1.0

—

(40763791) Oxygen content in Venous blood by calculation

1.61

0.70

14.3

6.7

13.22

12.14

ml/dl

0.66

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.70

0.69

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.54

0.69

1.0

1.1

3.33

2.88

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

643

1.17

0.68

1.1

1.2

333.63

302.22

pmol/l

0.27

467

(3011897) Casein IgE Ab [Units/volume] in Serum

534

1.19

0.68

1.1

1.2

2.54

1.83

u/ml

0.11

528

(3038515) Glucose [Moles/volume] in Venous blood

519

5463

0.94

0.67

3.9

3.3

7.31

7.53

mmol/l

1.08

504

5341

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

458

4834

0.94

0.66

1.5

0.35

0.38

nmol/l

0.37

342

3660

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

247

0.72

0.65

1.5

1.3

22.08

21.34

mmol/l

0.19

188

(1761482) Bacteria [#/volume] in Urine by Culture

613

6415

0.95

0.65

4.6

4.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

445

1.21

0.65

1.7

1.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

170

1.34

0.65

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

152

1678

0.90

0.64

1.1

1.0

0.41

1.04

u/ml

0.81

403

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.58

0.64

1.0

1.1

—

371.20

—

(40758292) HTLV I+II Ab panel - Serum

533

0.82

0.63

1.2

1.4

—

(3007733) Chloride [Moles/volume] in Urine

1.56

0.63

1.5

1.3

80.73

81.53

mmol/l

0.02

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

145

1.37

0.63

3.2

3.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

520

1.18

0.63

8.8

6.6

69.20

69.17

0.00

397

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3287

33339

0.98

0.63

4.5

5.0

33.73

32.48

8.92

2473

22407

(3008037) Lactate [Moles/volume] in Venous blood

692

6554

1.05

0.63

3.4

3.2

1.42

1.56

mmol/l

5.69

672

6403

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.46

0.62

1.1

325.11

195.49

pmol/l

—

(3014891) Appearance of Pleural fluid

304

1.24

0.61

1.6

1.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

251

1.27

0.61

1.3

14.10

15.00

nmol/l

—

(3001556) Androgen free Index in Serum or Plasma

243

0.74

0.60

1.1

1.2

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

2.35

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.58

0.60

5.8

8.6

49.80

46.38

—

(3027035) Albumin [Mass/time] in 24 hour Urine

243

1.27

0.60

1.3

207.14

265.71

mg/24h

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

219

0.73

0.59

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

242

2596

0.93

0.58

1.4

1.3

9.22

8.54

mmol/l

1.41

227

2463

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

942

9718

0.96

0.57

1.7

1.8

—

20.14

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

131

1.37

0.57

1.4

1.3

—

(44806420) Estimation of glomerular filtration rate

356

3322

1.07

0.57

2.8

2.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

114

1.39

0.57

1.4

1.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

362

1.21

0.56

1.3

1.4

52.85

52.37

0.03

179

(3010370) Gastrin [Moles/volume] in Serum or Plasma

472

1.18

0.56

1.4

1.9

128.83

50.48

pmol/l

0.52

398

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.58

0.56

1.6

2.0

273.20

237.35

ug/l

—

(40763590) HLA-DQ beta [Type]

106

1.41

0.55

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

205

0.73

0.55

1.0

1.1

20.86

5.46

u/ml

—

125

(3006598) pH of Arterial cord blood

123

0.65

0.54

1.4

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

123

0.65

0.54

1.4

1.0

7.00

7.06

kpa

—

(3032868) Hemoglobin electrophoresis panel in Blood

249

0.76

0.54

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

141

1.34

0.54

1.2

1.1

—

(46236302) HLA-C [Type] by High resolution typing

107

1.39

0.53

1.0

—

(40760409) HLA-A [Type] by High resolution

107

1.39

0.53

1.0

—

(40760410) HLA-B [Type] by High resolution

107

1.39

0.53

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

212

1.27

0.53

1.4

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

368

0.81

0.52

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

403

1.18

0.51

1.1

—

(4212803) Bone marrow aspirate examination

231

1.25

0.51

1.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

134

1.33

0.51

1.0

0.04

0.52

u/ml

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

678

0.86

0.51

1.1

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

442

1.17

0.49

1.6

124.21

109.81

ug/l

0.43

366

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

332

1.20

0.49

3.3

2.3

0.72

0.62

u/field

0.27

332

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

307

3238

0.94

0.48

2.7

3.6

23.42

7.70

nmol/l

0.41

294

3132

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

1.48

0.47

1.7

2.0

14.00

17.67

ng/l

—

(3016244) Insulin [Units/volume] in Serum or Plasma

201

1856

1.08

0.47

3.3

3.1

23.03

26.13

mu/l

0.77

189

1753

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

133

1444

0.91

0.46

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

318

0.81

0.45

1.2

6.23

5.88

mmol/l

0.38

318

(3021706) Oxygen [Partial pressure] in Arterial cord blood

120

0.66

0.45

1.4

1.1

5.01

3.74

kpa

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

184

0.76

0.43

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

528

0.87

0.41

1.0

1.1

2.12

6.14

u/ml

0.91

345

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.40

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.40

0.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

442

1.15

0.40

2.1

2.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

185

1.24

0.39

2.6

5.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

546

1.13

0.39

3.6

5.2

44.79

57.99

u/l

0.83

532

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.38

0.39

1.3

1.1

—

mmol/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

311

0.83

0.38

1.0

0.04

0.89

u/ml

—

156

(3018851) Theophylline [Moles/volume] in Serum or Plasma

246

0.81

0.38

1.2

1.8

40.80

49.28

umol/l

0.96

246

(3034614) HLA Ag [Interpretation]

1.35

0.38

1.1

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

23010

229257

0.99

0.37

35.9

19.3

330.48

332.17

g/l

152.05

22918

227989

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

117

1260

0.92

0.37

1.5

1.8

3.45

2.68

u/ml

0.22

342

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

251

1.19

0.37

1.5

1.4

4.35

15.92

pmol/l

5.02

205

(3025549) Creatine [Moles/time] in 24 hour Urine

224

1.20

0.36

1.4

—

13.38

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

489

0.87

0.36

1.2

1.6

0.23

0.25

nmol/l

0.14

350

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

493

4718

1.04

0.36

1.2

1.3

50.65

31.26

u/l

1.26

441

4082

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

125

1.27

0.35

5.6

9.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

148

1373

1.07

0.34

1.6

1.8

146.90

662.74

pmol/l

0.65

208

(4094501) Cardiovascular stress test using bicycle ergometer

768

7850

0.97

0.34

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

403

1.13

0.33

1.2

60.70

63.47

ug/l

0.42

403

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.69

0.33

1.0

1.1

21.90

46.75

umol/24h

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

236

1.18

0.32

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

404

1.13

0.32

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

190

1783

1.06

0.32

6.3

7.2

20.73

69.40

ug/l

1.60

116

1146

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

114

1219

0.93

0.32

2.3

2.1

110.61

104.60

ug/min

0.03

259

(3014599) Egg white IgE Ab [Units/volume] in Serum

175

1842

0.94

0.31

1.1

1.68

4.66

u/ml

0.78

460

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1973

19289

1.02

0.31

2.0

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

815

0.91

0.31

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

171

1604

1.06

0.30

1.5

1.31

1.25

nmol/l

0.30

129

1218

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

474

1.11

0.29

2.1

1.9

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

138

1.22

0.29

1.0

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

240

1.16

0.28

1.2

98.03

104.17

ug/l

0.11

149

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

117

0.76

0.27

1.0

1.1

240.00

283.73

nmol/l

—

117

(37021550) Renin [Units/volume] in Plasma --upright

562

1.10

0.27

1.2

1.3

52.18

83.50

mu/l

0.78

410

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

486

1.10

0.27

4.7

1.9

1.18

1.19

mmol/l

0.60

467

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.27

0.27

1.0

0.04

0.06

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

477

4883

0.97

0.26

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1606

16200

0.98

0.25

1.4

29.96

28.43

iu/l

1.02

1384

13896

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.19

0.24

1.0

2.07

3.73

u/ml

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

169

1.18

0.24

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

344

3307

1.03

0.24

1.6

1.7

328.54

380.97

mu/l

2.32

284

2658

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

164

1710

0.95

0.24

1.3

3.82

4.79

umol/l

3.20

145

1514

(3041806) Other cells [#/volume] in Blood by Manual count

873

0.93

0.23

1.6

1.5

0.51

e9/l

0.06

873

(3013139) Helicobacter pylori Ag [Presence] in Stool

2069

20808

0.99

0.23

1.2

1.3

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.31

0.23

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

304

0.88

0.22

1.1

1.4

—

1.98

mmol/l

—

(3024869) Neuronal Ab [Presence] in Serum

502

1.09

0.22

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

314

0.89

0.22

1.0

0.02

2.06

u/ml

—

150

(3029612) Listeria sp Ab [Titer] in Serum

1.21

0.22

1.6

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

171

1.16

0.21

5.2

3.5

21.35

10.24

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

481

4659

1.03

0.21

1.4

27.99

29.24

u/l

0.35

391

3801

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.8

—

139.40

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.18

0.21

1.0

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

302

0.89

0.21

1.1

1.4

—

0.88

mmol/l

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.20

0.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

312

0.89

0.20

1.9

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

391

1.09

0.19

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

600

5838

1.02

0.19

2.0

1.9

198.79

197.85

pmol/l

0.09

568

5557

(3009214) Lutropin [Units/volume] in Serum or Plasma

845

8253

1.02

0.19

1.4

12.15

11.02

u/l

1.32

698

6629

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

459

4454

1.02

0.19

1.1

48.59

3127.53

iu/ml

0.67

106

900

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

153

0.84

0.19

1.0

—

(4133840) Spirometry

730

1.06

0.18

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

731

1.06

0.18

2.1

1.8

—

(3003577) Lead [Moles/volume] in Blood

225

0.88

0.17

1.9

1.4

0.36

0.22

umol/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

130

1238

1.04

0.17

2.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

214

2059

1.03

0.17

2.5

3.5

156.65

147.39

nmol/l

0.08

208

2031

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

358

3642

0.98

0.16

1.4

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

376

1.08

0.16

3.1

2.2

1.29

1.33

mmol/l

0.03

256

(3011841) English Walnut IgE Ab [Units/volume] in Serum

296

0.91

0.16

1.0

1.1

0.58

2.88

u/ml

1.80

227

(3020191) Ethanol [Moles/volume] in Serum or Plasma

229

2340

0.97

0.15

1.4

1.5

1.08

1.28

promille

1.35

187

1817

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

274

0.91

0.15

1.1

1.0

2.28

0.57

u/ml

—

129

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

243

0.90

0.15

1.1

1.0

0.01

1.17

u/ml

1.89

173

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

417

1.07

0.14

1.5

2.6

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

187

1.12

0.14

1.0

1.2

34.14

21.56

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

149

1.13

0.14

1.1

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

159

1.12

0.14

1.7

1.6

0.83

0.74

umol/l

0.50

120

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

112

1.15

0.13

1.2

1.3

0.71

1.17

u/field

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

197

1904

1.03

0.13

1.3

1.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

292

0.92

0.13

1.0

0.03

1.09

u/ml

—

143

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.16

0.12

4.3

4.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

528

1.05

0.12

2.0

2.2

8.24

7.32

mmol/l

0.40

312

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

334

1.07

0.12

2.8

3.5

38.60

41.17

umol/l

0.30

286

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

422

1.06

0.11

1.0

4.18

11.08

u/ml

2.21

422

(46235168) Fasting glucose [Moles/volume] in Blood

310

0.93

0.11

1.4

2.1

6.07

7.72

mmol/l

—

111

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

584

0.95

0.11

1.4

1.9

3.00

2.67

ug/l

0.12

363

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

207

0.91

0.10

1.1

1.0

0.07

0.19

u/ml

0.88

207

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.08

0.09

1.2

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

175

0.91

0.09

1.0

1.1

2.67

0.87

u/ml

0.29

125

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

620

0.96

0.09

1.1

30.28

28.32

iu/ml

0.10

620

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.05

0.08

2.0

2.1

17.98

29.90

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

116

1.11

0.08

1.1

0.00

1.68

u/ml

1.78

116

(43055514) Macroprolactin [Presence] in Serum or Plasma

711

1.03

0.08

1.5

1.4

—

(3042517) Benzodiazepines panel - Urine

340

1.05

0.07

1.8

2.4

—

(3018001) Oat IgE Ab [Units/volume] in Serum

203

0.93

0.07

1.0

0.12

0.22

u/ml

0.76

115

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.84

0.07

1.1

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.83

0.07

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

405

0.96

0.07

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

303

0.95

0.06

1.1

1.0

0.19

0.24

u/ml

0.08

192

(3007542) Rye IgE Ab [Units/volume] in Serum

161

0.93

0.06

1.1

1.0

0.09

0.48

u/ml

—

(3029396) Erythrocyte agglutination [Presence] in Blood

744

0.97

0.05

3.0

2.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

332

3330

0.99

0.05

1.0

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

148

1.07

0.05

1.1

1.3

—

11476.25

—

(3016031) Almond IgE Ab [Units/volume] in Serum

207

1.06

0.05

1.1

1.0

0.07

0.84

u/ml

—

116

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

131

1322

0.98

0.05

1.1

12.40

8.76

u/ml

0.39

224

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

789

7879

0.99

0.04

1.8

43.98

41.98

nmol/l

1.26

776

7692

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

279

0.96

0.03

1.1

1.61

1.72

umol/24h

0.52

279

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

148

0.94

0.03

1.3

1.5

507.36

494.66

nmol/l

0.06

148

(3021387) Prolactin [Units/volume] in Serum or Plasma

1023

10194

1.00

0.03

1.8

1.7

294.90

306.10

mu/l

0.51

928

9231

(3033923) Metanephrine [Moles/time] in 24 hour Urine

587

0.98

0.02

1.1

0.66

0.80

umol/24h

0.56

278

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

297

0.97

0.02

1.0

1.1

0.70

2.05

u/ml

0.78

228

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6789

67402

1.00

0.02

4.9

5.4

2.36

3.11

ug/l

3.43

6121

61139

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

436

0.98

0.02

1.0

75.00

81.45

ug/l

0.58

332

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1585

15752

1.00

0.00

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

197

1.01

0.00

1.0

0.08

1.84

u/ml

1.37

161

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

218

1.00

0.00

1.3

1.2

40.51

44.83

mg/l

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

585

1.00

0.00

1.1

1.67

2.24

u/ml

0.20

498

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

558

5548

1.00

0.00

1.7

2.0

0.92

0.86

nmol/l

1.14

481

4690

(4038314) Semen analysis, post vasectomy

151

0.99

0.00

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

192

1911

1.00

0.00

1.1

3.78

1.81

u/ml

0.26

625

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.99

-0.00

1.2

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.94

-0.00

1.0

1.3

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

0.94

-0.00

1.0

1.5

0.20

0.43

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.4

—

315.20

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.0

—

3.12

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.96

-0.00

1.2

1.1

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

-0.00

0.0

3.4

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

7.8

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.8

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

-0.00

0.0

7.6

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

9.5

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_REIMB_202 and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_REIMB_202	1.314 [1.22, 1.42]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 8245 out of 64395 females with K11_REIMB_202 died.

Males

Parameter	HR [95% CI]	p-value
K11_REIMB_202	1.311 [1.21, 1.43]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 6319 out of 37085 males with K11_REIMB_202 died.

Mortality risk

Mortality risk for people of age

years, who have K11_REIMB_202.

N-year risk	Females	Males
1	0.107%	0.247%
5	0.617%	1.376%
10	1.571%	3.463%
15	2.981%	6.795%
20	5.143%	11.778%

Relationships between endpoints

↥

Index endpoint: K11_REIMB_202 – Reimbursement for rheumatic diseases

GWS hits: 62

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Reimbursement for rheumatic diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints